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Abstract 
 
Although synthetic preservatives and antioxidant may provide high antimicrobial 
and antioxidant effectiveness, they are usually associated with adverse reactions Currently, 
there is an increasing desire for high quality, with fewer chemicals, and long-term 
pharmaceutical products. Thus, there is an urgent need to develop moderate 
pharmaceutical products use of protected natural materials from microbiological growth 
during storage and use. The aim of this study was to evaluate the antimicrobial activity and 
antioxidant activity of olive leaves extract and oleuropein .The main active compound of 
the olive leaf extract) as well as thyme oil against three bacteria (one gram-positive and 2 
gram-negative) and two fungi (one yeast and one mold) in agar method. Those with such 
activity (working against two gram-negative bacteria, one gram-positive bacteria, one yeast 
and one mold) can be used as preservatives and will, therefore, be used as a preservative in 
a pharmaceutical syrup to replace chemical preservatives (methyl-propylparaben and 
benzalkonium chloride), and replacing Butylhydroxytoluene as chemical antioxidant.  
In this work, oleuropein with different concentrations (0.2, 0.4 and 0.6 % w/v ) and 
extracts of olive leaves with concentrations (0.2, 0.3 and 0.4% w/v) and thyme oil with 
concentration   (0.1% v/v ) and a mixture of oleuropein and thyme oil with concentration 
(0.4% w/v and 0.1% v/v ) were examined as natural antimicrobial preservatives in 
pharmaceutical syrups and very promising results were obtained. Results showed that 
oleuropein can be used as preservatives with concentration (0.6 w/v), extract of olive leaf 
with concentration (0.4 w/v) and mixture between oleuropein and thyme oil with 
concentration (0.4 and 0.1 v/v) The results showed that thyme oil and oleuropein have 
synergistic activity of against microbes. Laboratory pharmaceuticals were analyzed in 
terms of the percentage of active substance using HPLC and antimicrobial activity in 
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microbiological laboratories and physical properties. The results showed that 
pharmaceuticals preparations were stable and effective for three months on accelerated 
Condition (40±2 °C /75%±5% RH). 
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Chapter One 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
: Introduction 
 
1.1 Antimicrobial activity 
Antimicrobial preservatives are materials added to pharmaceutical products to 
inhibit the growth of microorganisms introduced through the manufacturing process or 
during usage and storage (E.O. Akinkunmi et al., 2010). Adding antimicrobial 
preservatives to sterile products packaged in multiple-dose containers can inhibit the 
growth of microorganisms that could be accidentally introduced during repeated 
withdrawal of individual doses. These preservatives in finished dosage forms meet the 
requirements for added substances under limitations (V.W.C. Sutton et al., 2002). 
Antimicrobial agents may contain toxic materials. Have been reported (J. breilkreutz et al., 
2007), (N. Shehab et al., 2009) e.g. for benzyl alcohol, coloring agents, propylene glycol, 
ethanol and propylparaben Antimicrobial agents may contain toxic materials. Thus, it is 
essential to add the effective concentration of the preservatives to packaged products 
taking in consideration that it is under a level that may be toxic to humans (J. breilkreutz et 
al.,2007) and An antioxidant is a molecule that inhibits the oxidation of different  
molecules. oxidation is a chemical process that transfers electrons or hydrogen from a 
substance to an oxidizing agent. oxidation reactions will produce free radicals. In turn, 
these radicals will begin chain reactions, once the chain reaction happens in a cell, it will 
cause damage or death to the cell. Antioxidants stop these chain reactions by removing free 
radical intermediates, and inhibit different oxidation reactions (Marino et al., 1999).                                                                                                   
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Recently, natural antimicrobial agents have been extensively tested and used instead of 
chemical agents in the pharmaceutical industry. Chemical preservatives are notorious for 
their carcinogenic attributes and residual toxicity as compared to the safer natural 
antimicrobial agents (N. Shehab et al., 2009). Chemical preservatives are dangerous to use 
in pediatric formulations for their toxicity and have many cause side effects on children. 
Therefore, recent research has been focused on natural antimicrobial agents to investigate 
their preservation abilities and identify the specific effective substance to expand the 
spectrum of antimicrobial activity over that of the regulatory approved substances. 
Naturally derived compounds and other natural products may have applications in 
controlling bacteria in Pharmaceutical dosage form (V.W.C. Sutton et al., 2002).                                                                                             
One group of naturally derived antimicrobial compounds is medicinal plants and their 
essential oils. These compounds are safe, have a certain degree of antimicrobial activity, 
and could inhibit the growth of pathogens and spoilage microorganisms thereby improving 
the shelf life of pharmaceutical products (M. Mari et al., 2003; J. Obagwuet al., 2003). The 
ability of medicinal plant extracts to control the growth of pathogens and spoilage bacteria 
and their use as alternatives to conventional natural preservatives is emerging because they 
are generally safe to humans, and friendly to the environment (R. Thangavelu et al., 2004).                                                                        
There is an increasing interest in phytochemicals as new sources of natural antioxidant and 
antimicrobial agents. The use of synthetic antioxidants in the food industry is severely 
restricted as to both application and level (K. TAWAHA et al., 2007; Y. PENG et al., 
2005). Currently, there is a strong debate about the safety aspects of chemical 
preservatives, since they are considered responsible for many carcinogenic and teratogenic 
attributes, as well as residual toxicity (M.R. MOREIRA et al., 2005). 
The effectiveness of natural plant extracts need to be evaluated to specify their 
antimicrobial activity and potential side effects in packaged pharmaceutical products. 
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Therefore, the study of the antimicrobial activity of some medicinal plants extract has 
become an important research interest and a big challenge. (H. Shtaya, 2015).   
1.2 Olive leaves extract  
The olive tree, botanically-classified as Olea europaeaL.is one of the most 
important fruit trees in Mediterranean countries. The characteristic green to blue-black fruit 
of this shrub yields useful edible oil. Both the oil and the dried green-grayish colored 
leaves are used medicinally (Wernet al., 1985). The olive tree has been held in high esteem 
throughout history. The oil is symbolic of purity and goodness, while the olive branch 
represents peace and prosperity. Historically, the knowledge of the medicinal properties of 
the olive tree date back to the early 1800s, when it was used in liquid form for malaria 
treatment (Wernet al., 1985). In the early 1900s a bitter compound was found in the leaves 
of certain olive trees called "oleuropein," which was thought to be part of olive tree's 
potent disease-resistant structure (Walker et al., 1997). The olive tree has been the source 
of natural healing agents down through the ages including the olive oil produced from its 
fruit. For centuries, teas and other preparations made from olive leaves have been used 
successfully to treat fevers and gastrointestinal complaints, including parasites in human 
patients. Olive leaf extract is effective against a broad spectrum of microbial agents, 
including viruses, bacteria and even parasites, and can considered one of the most useful 
and safe natural anti- microbial herbal extracts yet discovered (Pooleyet al., 1997). It can 
inhibit and kill over 100 microorganisms which can cause disease, and death on a broad 
scale, thus it can be considered nature antibiotic remedy to be used to prevent and treat 
numerous animal infectious conditions and health problems related to: viruses, bacteria, 
parasites, allergy conditions, skin problems (psoriasis), inflammation (arthritis, sinusitis, 
bursitis, etc.), gastrointestinal problems, ulcers, free radical overload, overburdened 
immune system, and wound healing. 
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Olive leaf extract was derived from the leaves of the olive tree. It is a source of many 
phytochemicals. It was found to be part of a compound produced by olive trees that make 
them particularly vigorous and resistant to insect and bacterial damage (Pooley et al., 
1997) The OleaeuropaeaL. leaves represent a typical herbal drug of the Mediterranean 
area, commonly used in traditional medicine as vasodilatory, hypotensive, anti-
inflammatory, antirheumatic, diuretic, antipyretic, and hypoglycemic agents (Somovaet al., 
2000). The active constituents of olive leaf have a wide number of ingredients, including 
the chief constituent oleuropein (60-90 mg/g) and several types of polyphenolic 
compounds. The following polyphenols were detected in olive leaf tissue: oleuropein, 
hydroxytyrosol, tyrosol (figure (1.1), elenolic acid derivatives, caffeic acid, oleuropein, 
verbascoside, rutin, luteolin 7-O-glucoside, luteolin 4-O-glucoside, apigenin-7-O-
rutinoside and apigenin 7-O-glucoside (Benavatet al., 2000). There are at least six active 
substances (oleuropein, hydroxytyrosol, caffeicacid, vanillin, luteolin-7-glucoside, and 
verbascoside) in the extract. These six substances work together synergistically to prevent 
resistance by pathogen microorganisms. While oleuropein is the ingredient most studied, 
there are in fact 95 different chemicals in the leaf and a balance of ingredients seems to 
work the best. Oleuropein content varies from17% to 23% depending upon the time of year 
the leaves are harvested (Le toutouret al., 1992). 
 
Oleuropein 
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Hydroxytyrosol 
 
Tyrosol 
 
Figure (1.1): Chemical structure of oleuropein, hydroxytyrosol and tyrosol. 
1.2.1 Oleuropein 
Oleuropein (figure (1.1) is a natural product of secoiriodoid group; hetrosidic ester 
of elenolic deteracid and 3,4-dihydroxyphenyl ethanol, containing a molecule of glucose, 
the hydrolysis of which yields elenolic acid glucoside and hydroxytyrosol. Many 
molecules isolated from Oleaeuropea fruits or leaves are thought to have been originated 
from Oleuropein via aglycon, by the opening of elenolic acid ring with a final 
rearrangement into the secoiridoid compound, such as hydroxytyrosol( Syedet al., 2010).  
The amount of oleuropein in olive leaves depends on several factors, including 
oleaeuropea variety, time collection, possible infestation by olive fly DacusOlea, climate, 
conditions of storage, and the methodology of extraction. Oleuropein content varies from 
17%-23% depending on the time of year the leaves are harvested. 
  
1.2.1.1Pharmacological properties of Oleuropein 
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Oleuropein has several pharmacological properties, including antioxidant, anti-
inflammatory, anti-atherogenic, anti-cancer, antimicrobial, and antiviral, and for these 
reasons, it is commercially available as food supplement in Mediterranean countries. In 
addition, Oleuropein has been shown to be cardioprotective against acute adriamycin 
cardiotoxicity and has been shown to exhibit anti-ischemic and hypolipidemic activities 
(Syed et al., 2010), figure 2. 
 
 
 
 
 
 
 
 
 
 
Figure (1.2): Pharmacological effects of Oleuropein 
1.2.1.2 Antioxidant activity: 
Oleuropein has high antioxidant activity in vitro, comparable to a hydro-soluble 
analog of Tocopherol. Oleuropein scavenges superoxide anions and hydroxyl radicals, and 
inhibits the respiratory burst of neutrophils and hydrochlorous acid-derived radicals 
(Visioli et al., 2002). 
1.2.1.3 Anti-inflammatory effect: 
 
OLEUROPEIN 
Antioxidant 
Anti-inflammatory 
Skin protectant 
Anti-aging Anti-atherogenic 
Anti-viral 
Anti-cancer 
Anti-microbial 
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Recent studies showed that Oleuropein increases nitric oxide (NO) production in 
macrophages challenged with lipopolysaccharide through induction of the inducible form 
of the enzyme nitric oxide synthase, thus increasing the functional activity of these 
immunocompetent cells. It is well known that Oleuropein elicits anti-inflammatory effects 
by inhibiting lypoxygenase activity and the production of leukotriene B4 (Visioliet al., 
1998). 
1.2.1.4 Antimicrobial effect: 
Oleuropein has been shown to have strong antimicrobial activity against both 
Gram-negative and Gram-positive bacteria as well as mycoplasma. Phenolic structures 
similar to Oleuropein seem to produce its antibacterial effect by damaging the bacterial 
membrane and/or disrupting cell peptidoglycans. The exact mechanism of the 
antimicrobial activity of Oleuropein is still not completely established, although some 
authors have proposed that it is due to the presence of the ortho-diphenolic system 
(catechol)(Owenet al.,2000). 
1.2.1.5 Skin protectant: 
Recent studies have shown that the phenol components of olive leave have a direct 
antioxidant action on skin, especially Oleuropein, which acts as a free radical scavenger at 
the skin level (Ancoraet al.,2004). 
1.2.1.6 Anti-aging: 
Normal human fibroblasts undergo replicative senescence due to both genetic and 
environmental factors. The proteasome, a multicataly ticnonly sosomal protease, has 
impaired function during aging, while its increased expression delays senescence in human 
fibroblasts. Oleuropein enhances proteasome activities in vitro more effectively than other 
known chemical activators, possibly through conformational changes of the proteasome. 
Moreover, continuous treatment of early passage human embryonic fibroblasts with 
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Oleuropein decreases the intracellular levels of reactive oxygen species (ROS), reduces the 
amount of oxidized proteins through increased proteasome-mediated degradation rates and 
retains proteasome function during replicative senescence. Importantly, Oleuropein-treated 
cultures exhibit a delay in the appearance of senescence morphology, and their lifespan 
extended by approximately 15 % (Katsikiet al., 2007). 
 
1.2.1.7 Other activities: 
Further pharmacological activities of Oleuropein includes diverse healing 
properties due to its vasodilatory, anti-platelet aggregation, hypertensive, anti-rheumatic, 
diuretic and antipyretic effects. Prevention of free radical formation by Oleuropein occurs 
through its ability to chelate metal ions, such as Cu and Fe, which catalyze free radical 
generation reactions, and through its inhibitory effect on several inflammatory enzymes 
like lipoxygenases. Previously, Oleuropein was reported to have an anti-hyperglycemic 
effect in diabetic rats. Oleuropein inhibits hyperglycemia and oxidative stress induced by 
diabetes, which suggests that administration of Oleuropein is helpful in the prevention of 
diabetic complications associated with oxidative stress (Syedet al., 2010). 
 
 
 
Figure (1.3): Olive leaves extract 
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1.3 Thyme (Thymus Vulgaris) 
Are aromatic plants of the Mediterranean region and common herb in North Africa, 
and is commercially cultivated in large scale in many countries. It belongs to the Mint 
family, Labiatae. Thyme is herbaceous perennials subshrubs with a bushy, woody-based 
evergreen plant, rarely grows more than 40cm tall, with highly aromatic, tiny, gray-green 
leaves which is responsible for its characteristic flavor and fragrance. beautiful purple 
flowers bloom in the early summer. Thyme plant is an easy to grow on rocky soil and hot, 
dry condition, which requires little or no care (M.Coisin, et al 2012) are showed in figure (1.4). 
Thyme species are used as a traditional medicine as herbal tea to treat cold, flu and cough. 
It has been reported that thyme, in general, contain various medicinal benefits and used as 
carminative, digestive, antispasmodic, anti-inflammatory and expectorant.                                                                                                                  
The essential oils whit in thyme species contains large amounts of thymol, which is strong 
antibacterial agent (E.Basch,et al 2004)as well as a strong antiseptic and antioxidant 
(B.Imelouane, et al 2009). 
Thymus vulgaris essential oil is a mixture of monoterpenes. The two main compounds of 
this oil are the natural terpenoidthymol and its phenol isomer carvacrol which are showed 
in figure (1.5) (A.Grigore et al 2010). 
 
 
Figure (1.4): Thyme leaves 
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Figure (1.5): Chemical structure of Thymol and Carvacrol 
 
1.3.1 Chemical Composition of the Essential Oil of thyme 
The essential oil from T. vulgaris showed a high content of oxygenated 
monoterpenes (56.53%) and low contents of monoterpene hydrocarbons (28.69%), 
sesquiterpene hydrocarbons (5.04%) and oxygenated sesquiterpenes (1.84%) (Almaqtari M 
et al.,2011) . The predominant compound among the essential oil components was thymol 
(51.34%) while the amount of all other components of the oil was less than 19%. 
 
1.3.2 Pharmacological properties of thyme oil 
1.3.2.1 Anti Inflammattory Property  
Thymus vulgaris oil is a mixture of monoterpenes. the most compounds of this oil 
are the natural terpenoid thymol, phenol chemical compound carvacrol(Amiri H et al 2012 
and Nickavar B et al 2005) that have antioxidative, antimicrobial, used in medicinal drug, 
antitussive, antispasmodic, and antibacterial effects (Hoferl M et al 2009 and ESCOP 
(2007)). 
 
1.3.2.2 anti bacterial activity 
The efficacy of aromatic oils obtained from Thymus vulgaris L. was tested 
against nine strains of gram-negative bacteria and six strains of gram-positive bacteria. To 
detect the antibacterial activity of the selected essential oils and the parameter to illustrate 
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and measure the antibacterial activity of thyme oils was the detection time. Plate count 
technique was used to study the inhibitory effect by direct exposure. The result showed 
that thyme oil had a significant effect on microorganisms tested. A number of species were 
able to recover at least 50% of the metabolic function once they were connected to the 
inhibitor, while most strains were found to be almost completely inhibited (Marino et al., 
1999). 
1.3.2.3 Antioxidant properties 
The leafy parts of thyme and its oil are utilized in foods for the flavor, aroma and 
preservation and additionally in folk medicines. El-Nekeety conducted an experiment to 
work out the elements of Thymus vulgaris L. oil and to evaluate the protecting effects of 
this oil against aflatoxininduce oxidative stress in rats. The results indicated that the oil 
contains Carvacrol (45 mg/g), Thymol (24.7 mg/g), β-Phellandrene (9.7 mg/g), essential 
oil (4.1 mg/g), Humuline (3.1 mg/g), α-Phellandrene (2.3 mg/g) and Myrcene (2.1 mg/g) 
[10]. However, α and β-pinene, Myrcene, α-thyjone, Tricyclene, 1, 8-cineole, and β-
sabinene were found in very lower concentrations. Treatment with aflatoxins alone disturbs 
lipid profile in blood serum, decreases total antioxidant capability, increased creatinine, 
uric acid and nitric oxide in blood serum and lipid peroxidation in liver and excretory 
organ attended with a sever histological changes within the liver tissues. The oil alone at 
the 2 tested doses didn’t induce any important changes within the biochemical parameters 
or the histological image. The combined treatment showed important enhancements 
altogether tested parameters and histological footage within the liver tissues. Moreover, 
this improvement was additional pronounced within the cluster received the high dose of 
the oil (Prasanth Reddy V  et al., 2014). 
 
12 
 
1.4 objectives 
The objectives of this study are: 
1. To extract olive leaves using ethanol (80%). 
2. To extract thyme oil from thyme plant using Steam distillation. 
3. To determine the antimicrobial activity of pure oleuropein (pharmacopeial grade) on 
clinical bacterial and fungal isolates and compare that with routinely used 
preservatives.  
4. To determine the antimicrobial activity of Olive leaves extract (OLE) on clinical 
bacterial and fungal isolates and compares that with routinely used preservatives. 
 
The Antimicrobial Effectiveness Test or efficacy test will be done on the following 
standard reference organisms:  
 Candida albicans(ATCC No. 10231) 
 Aspergillus niger(ATCC No. 16404) 
 Escherichia coli (ATCC No. 8739) 
 Pseudomonas aeruginosa (ATCC No. 9027) 
 Staphylococcus aureus (ATCC No. 6538). 
 
5. Incorporate oleuropein and essential of thyme oil  and OLE into pharmaceutical 
preparations (containing dexamethasone sodium phosphate as active ingredient and 
methyl and propylparaben as chemical preservative and Sodium chloride Nasal Spray 
containing Sodium chloride (NaCl) as active ingredient and benzalkonium as chemical 
preservative and vitamin D3 Oral drops containing vitamin D3 as active ingredient and 
Butylhydroxytoluene as a chemical antioxidant. 
6. Investigate the optimum concentration of oleuropein, and OLE and thyme oil in the 
syrup as natural preservative/antioxidant and compare it with methyl and 
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propylparaben and benzalkonium chloride and Butylhydroxytoluene as the antioxidant. 
7. Evaluate the antimicrobial effectiveness of the pharmaceutical preparations containing 
oleuropein or OLE or a mixture of oleuropein and thyme oil, and compare it with 
pharmaceutical syrups containing  chemical preservatives as (positive control product). 
8. study the stability of the pharmaceutical preparations in terms of (% of the active 
ingredient: dexamethasone sodium phosphate, Sodium chloride (NaCl), vitamin D3) 
and % of oleuropein. 
 
 
Chapter Two 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
Literature Review 
 
2.1 Literature Review 
On reviewing available literature, it is evident that extensive research has been 
carried out to address various aspects of evaluating the effectiveness of natural plant 
extracts to determine their antimicrobial activity and potential side effects in 
pharmaceutical products.  With this in mind, in an attempt to simplify the topic and delimit 
the subject to some extent, this chapter will focus primarily on the work that has been 
carried out the approximation of antimicrobial activity systems. 
The main objective of this chapter is to provide a look at the theoretical and practical 
aspects concerning OLE antimicrobial activities and compare their effectiveness. This 
includes examining OLE and thyme oil as preservatives for pharmaceuticals. Therefore, 
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studying the antimicrobial activity of some medicinal plant extracts has become an 
important research concern and a major challenge. 
  
2.2 Antimicrobial activity of OLE  and thyme oil 
Nature is full of miracles. There are herbal properties for incredible and countless 
herbs. Currently patients are trending to use natural therapy (natural medicine) because of 
the significant side effects of synthetic drugs (Atia z et al 2007).  
The olive tree contains a high percentage of the biophenols such as oleuropein, 
verascascide, ligstrosides, tyrosol or hydroxyl tyrosol (Keskin D et al 2012). We will 
discuss some studies on activity against microbes, olive leaves and thyme oil 
(Furneri et al. 2002), In this study activity of OLE  was studied against gram  positive 
bacteria  and gram negative. The minimum inhibitory concentration was determined in the 
laboratory by a broth microdilution assay. Water was used as a solvent and the 
concentration used were (20-320 mg / ml) Microorganisms. The result of this study was 
that Oleuropein is more toxic for gram positive  bacteria  than gram negative   bacteria,  
where the conclusion of the study was that Oleuropein was found to be effective against  
mycoplasmas. There is a consistency with ( Aliabadi et al 2012) in a study against 
microbes where the bacteria were used mainly (Staphylococcus aureus PTCC 1431, 
Salmonella typhimurium PTCC 1639, and Escherichia coli PTCC 1399, Klebsiella 
pneumonia PTCC 1053, Bacillus cereus PTCC 1274). Water was used as a solvent and  
different concentrations were used (10-15-25-30-50) mg / ml Olive  leaf aqueous extract) 
as a result of the research Olive Leaf aqueous extract showed good antimicrobial abilities 
and highest inhibitory of 11.5 against salmonella typhi where there was a similarity in that 
the extract of olive leaves had the ability against microbes. The results were also consistent 
with (gumgumjee et al 2014),when three types of gram negative bacteria and three gram 
positive bacteria were used against agar assay method and antimicrobial activity was 
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determined by measuring the inhibitory zone by using petroleum ether , ethanol, ethyl 
acetate as in solvent and concentration of (200 mg / ml),  The results of this study (Ethanol 
extract is the most effective against all bacteria, while Petroleum ether extract of the leaves 
and stem showed no activity against  B. subtilis MRSA & S. aureus, as well as low activity 
against E. coli, Kpneumonia and  P. aeruginosa. Ethyl acetate extract of leaves  showed a 
moderate effectiveness against all bacteria.  
(Gokman et al., 2015), The effectiveness of the OLE may not be due to one main active 
constituent but may be due to the combine action of different compounds originally present 
in the plant. It was also consistent with the study where five gram-positive bacteria were 
evaluated for and five gram- negative using zone of inhibitory (ZOI) and MIC was 
determined by the concentration (50 mg / ml) and the result of this study was presented the 
highest antibacterial activity against Bcereus & the lowest antibacterial against S.typhy.  It 
was also agreed with the (Salma malik et al 2015); two types of Gram positive bacteria (S 
aureus & Bcereus) were evaluated using the zone of inhibitory (ZOI) and MIC was 
determined by using (methanol) as a solvent and concentration (500,1000,1500,2000 mg / 
ml) and the result of this study showed that OLE was effective against two gram positive 
strains. 
Markin et al. (2003).In this study, the method of In vitro scanning electron microscopic 
observation for candidia albicans was used. . The result of this study was (Deramatophytes 
were inhibited by 1.25 % (w / v) OLE following after three day, Candida albicans was 
killed following after 24 h in the presence of 15% (w / v) OLE ),  where the conclusion of 
this study was that "Olive leaves extract" shows antibacterial and antifungal properties. In 
addition to this study which was in 2014,(Lamprini et al 2014) using the MIC assay and 
MBC method (acetone, water) as solvent concentration of olive leaf extract (10 mg / ml) 
and the microorganisms used were bacteria and fungi  The result of this research  showed a 
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milder inhibitory effect against oral pathogen,  OLE were active against   the tested 
pathogens specifically gram- negative anaerobic bacteria. 
Battinelli et al., (2005), in  this study OLE was tested against bacteria and fungi where the 
method was used MIC and MFC (minimum fungicidal concentration),  The organisms 
were used are bacteria and fungus. 
The result of this study showed a different spectrum of antimicrobial activity and MFC 
values were the same of the MIC ones). The conclusion of this study was that OLE is 
useful material in the topical treatment of fungal cutaneous infection. 
The effectiveness of OLE against fungus was studied using the disc diffusion, method 
where it has been used over solvent (water, acetone, methanol, ethyl acetate) korukluoglu 
et al., (2007), the concentration used was used 30 mg / ml of extract of olive leaves and 
microorganisms. The conclusion of this study was that aqueous extract showed the most 
prominent activity. diethyl ether extracts of the olive leaves showed poor antifungal 
activity. 
Pereira et al., (2007) This research studied the effectiveness of OLE against microbes, the 
method used was in vitro MIC for the microbial inhibition of microbial, where water was 
used as a solvent and concentration 0.05-5 mg / ml, Gram positive (Bacillus cereus, B. 
subtilis and Staphylococcus aureus), Gram negative bacteria (Pseudomonas aeruginosa, 
Escherichia coli and Klebsiellapneumoniae), and fungi (Candida albicans and 
Cryptococcus neoformans). The result of this study showed that at low concentration OLE 
showed an unusual combined antibacterial and antifungal activity. The conclusion of this 
study was that extracts of olive leaves and oleuropein, have a potential effect against 
microbes. 
Sudjana et al (2009) had studied the effectiveness of OLE against the intestinal bacteria 
using agar dilution and broth microdilution techniques;  MIC, MBC & MFC were 
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determined, by using of the extract of olive leaves (4.4mg/ml) and micro organisms  (H. 
pylory and C. jejuni and Staphylococcus aureus, Listeria monocytogenes, Salmonella 
enteritidis, E. coli, Shigellasonnei and Yersinia sp).  The result of this study was that OLE 
may have a role in regulatory the composition of gastric flora by selectively reducing level 
of (H.pylory and C.jejuni); while the  result of this study was (Olive leaf extract has not 
broad spectrum in action showing appreciable activity only against (H.pylory, S.aureus, 
C.jejuni and  Methicillin-resistant Staphylococcus aureus). 
Erdohan et al., (2011); in this study, the extract of olive leaves was evaluated on agar 
diffusion method, chloroform (methanol) was used as a solvent. The concentration of olive 
leaf extract was (3 gr / 100ml), the result of this study was (OLE concentrate in the disks 
changed within range of 0.6 -3.6 mg and increasing OLE has a great potential in 
antimicrobial food package to reduce post-process growth of bacteria. 
Faiza et al.,( 2011); In this study antimicrobial activity of OLE was measured, using 
bacteria and fungus on agar disk diffusion method and measurement of diameters of 
inhibition zone. Ethyl acetate acetone was used as solvent and in extract concentrations of 
(10-15-20-30-50) mg / ml); the microorganisms used were Staphylococcus aureus ATCC 
25923,  Enterococcus feacalis ATCC 29212, Bacillus cereus ATCC 10876,  Escherichia 
coli ATCC 25922,  Pseudomonas aeruginosa ATCC 27853, Listeria monocytogenes 
ATCC 15313,  Klebsiella pneumonia ATCC 700603,  Enterobacter cloacae ATCC 13047, 
Citrobacterfreundii ATCC 8090, Proteus mirabilis ATCC 35659 and Salmonella 
typhemurium ATCC 13311) and fungi (Cladosporiumherbarum MNHN 3369, 
Alternariaalternaria MNHN 843390,  Aspergillus fumigates MNHN 566, Aspergillus 
flavus MNHN 994294). The result of this study was that all extract concentrations  showed 
good inhibitory effects toward E.coli & bacillus cereus as compared to other bacteria. 
Ethyl acetate and acetone extracts were more effective against  fungi. The conclusion of 
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this study indicates that olive leaves are a potent source of antibacterial and antifungal 
against. 
Altaf Hussain et al.( 2014); Activity of OLE has been studied. Agar disc diffusion method 
was used and zone of inhibition (ZOI) was measured. The results showed that OLE had 
potential antimicrobial activities against some of gram positive and gram negative bacterial 
strain. The findings of this study suggested that Leaf Extract is a cheap and effective 
antibacterial agent that can be used as alternative to purified oil. 
E.O. Dada (2013);in this study, Activity of OLE was evaluated against six bacterial 
pathogens: (Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Enterococcus 
faecalis, Pseudomonas aeruginosa and Salmonella enterica). Water and methanol was used 
as a solvent. 
The result of this study was (The methanolic extract, at a concentration of 50 mg / mL, 
exhibited the highest inhibitory potential on Salmonella enterica and Escherichia coli with 
a zone of inhibitory of 13.0 mm and 10.5 mm respectively while the aqueous extract had 
the highest inhibitory potential on Enterococcus faecalis and Escherichia coli with an 
inhibitory zone of 5.0 mm) obtained with the methanolic leaf extracts of the plant was from 
3.125 to 12.5 mg / mL and 12.5 to 25 mg / mL for the aqueous extract. 
(Atai et al., 2016)  in this review article evaluated the ability of extract olive leaves as 
antimicrobial;  the study contained 26 related scientific articles, including 21 evaluation of 
the effectiveness of (OLE) against bacteria and 3 studies of its effectiveness against viruses 
and 7 studies of the effectiveness against fungus (Figure 2.1). 
Majority of studies reported a great antimicrobial activity (figure 2.2) of OLE .most of 
them demonstrated that different solvent and concentration presents a significant 
effectiveness against microorganisms.  
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Figure (2.1): Type of microorganisms used in antimicrobial assessment of OLE 
 
 
Figure (2.2):Type of antimicrobial effect of  OLE . ++: studies which are effective against all 
tested microorganisms.+-:studies which are effective against some strains of tested 
microorganism .--: studies which  had no effect on tested microorganism.( Atai et al., 2016) 
 
Marija Bo skovic et al., (2015); this study had been evaluated the activity of thyme oil 
against microbes.  MICs were determined by broth microdilution method, the investigation 
of the antibacterial effects of thyme oil was performed on Staphylococcus aureus, and, 
Escherichia coli and Bacillus cereus, Salmonella Enteritidis, Salmonella Thyphimurium, 
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methicillin resistant Staphylococcus aureus, Salmonella Thyphimurium,  Staphylococcus 
aureus. The result of this study was thyme oil exhibited antibacterial activity against all 
tested microorganisms. 
(Bulent Cetin et al., 2011); in this study, an effective evaluation was performed against 
microbes effects of the essential oils from thyme and oregano. The test method  used  was 
DD and MIC methods. A total of 43 microorganisms were studied including 26 bacteria, 
14 fungal species and 3 types of yeasts. The result of this study was:  mean inhibitions and 
MIC values of bacterial strains varied from (8 and 72) mm to 7.8 and 500 μg mL-1, 
respectively. The maximal inhibiting zones and MIC values of the yeast and fungi species 
sensitive to the essential oils were 8-74 mm and 7.8-500 μg mL-1, respectively. The 
susceptibility of the tested microorganisms varied depending on the essentialoils of 
oregano and thyme may be considered a potential source of a natural antimicrobial for the 
food industry after testing the toxic and irritating effects on humans. 
Gavaric, N et al., (2015)  inthis study, antioxidant and antibacterial activities of thyme and 
oregano  essential oils, thymol and carvacrol, as well as their  possible synergism were 
investigated.  Antioxidant capacity was assessed throughout neutralization of DPPH and 
OH radicals. For determination of antibacterial activity against selected gram-positive 
(Staphylococcus aureus and Bacillus cereus) and gram-negative bacteria (Salmonella 
Infantis, Escherichia coli) by broth micro-dilution method was used, the combination 
testing for potential synergy of thyme and oregano essential oils, thymol and carvacrol was 
performed and evaluated with fractional inhibitory concentration. Thymol and carvacrol 
were found to be dominant component of investigated essential oils. 
All studied samples expressed strong antioxidant and antibacterial potential. In synergy 
testing, both combinations (thyme/oregano essential oils and thymol / carvacrol) were 
found to have additive effect (FIC=0.75). These results confirm thyme and oregano 
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essential oils, thymol and carvacrol as well as their combinations for possible application 
as natural additives in different products (food, cosmetics and nutriceuticals). 
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Chapter Thre 
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
 Materials and methods 
3.Materials and methods  
3.1 Materials and reagents: 
Materials and reagents used in this study are illustrated in Tables (3.1) and 
(3.2).  All materials used in the formulation of pharmaceutical preparations are of 
pharmaceutical grade.               
Table (3.1): List of materials used in the formulation of pharmaceutical preparations 
Materials of pharmaceutical preparations No. 
cremophor RH40 (polyoxyl40 
hydrogented castor oil) 
12 Dexamethasone sodium phosphate 1 
EDTA 13 Cherry flavor 2 
Sodium dihydrogen phosphate          14 Red color 3 
dibasic sodium phosphate                  15 Titreplex 4 
vitamin D3 crystals 16 Saccharin Sodium 5 
Tween 80 17 Sucrose 6 
Citric acid anhydrous 18 OLE 7 
Orange oil flavor 19 Glycerin 8 
Oleuropein 20 
Distilled water 
9 
  Sodium chloride (NaCl) 10 
  Thyme oil 11 
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- All reagents were of analytical grade table (3.2) these materials and reagents were 
purchased from reliable sources and donated by Beit Jala Pharmaceutical Co, Ltd / 
Bethlehem - Palestine. 
 
Table (3.2): List of materials used for extraction, formulation, chemical- physical-
microbiological analysis, and stability testing 
list  all materials and reagents  of analytical grade No. 
Letheen Broth, Letheen Agar 12 Olive leaves 1 
Broth media 13 Oleuropein 40% 2 
Sterile saline 14 Distilled  water Thyme leaves 3 
Poly sorbate 80 15 Acetic acid  4 
Fluid Lactose Medium 16 Ethanol 5 
Phosphate buffer stock solution 17 Methanol 6 
Eosin  Y 18 Ethylacetate 7 
Glacial acetic acid  19 Distilled  water 8 
Silver nitrate 20 Soybean-Casein Digest Medium 9 
HDPE bottles, LDPE Caps, Amber 
Glass Bottles type III 
 Soybean-Casein Digest Broth,  10 
  Casein Digest- soy Lecithin 
Polysorbate 
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3.2 Equipment and Tools 
Equipment and tools used for extraction, formulation, chemical- physical-microbiological 
analysis, and stability testing are illustrated in Table (3.3). 
All Syringes, vials, pipettes, glass ware, stands and tubes were supplied by Beit Jala 
Pharmaceuticals Company. 
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Table (3.3): list all Tools and Equipment used in the study 
 
1.3 Sample Collection and preparation 
3.3.1 Olive leaves 
Olive leaves samples were obtained from trees localized in Bethlehem in West Bank/ 
Palestine in November 2017. The leaves were dried at ambient temperature. Then the dried 
Equipment and Tools No. 
Laminar Flow Cabinet 1 
 Steam Autoclave 2 
Vortex 3 
UNIMAX 1010 shaker 4 
Spectrophotometer UV- visible 5 
pH meter 211R Hanna 6 
Mixer tank 7 
Sterile petri dishes (diameter of 9 cm) 8 
Plates 9 
Steam distillation Device  10 
Thermometer 11 
Extraction Tools 12 
Filters:  Whatman No.1 filter 13 
HPLC Apparatus 14 
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samples were grinded and passed through sieve mesh # 120 mm to obtain powder which 
was stored at room temperature in dark until extraction.  
3.3.2 Thyme leaves 
Thyme leaves samples were obtained from plants localized in Bethlehem in West 
Bank/ Palestine in December 2017, until oil is extracted from the leaves by Steam 
distillation. 
3.4 Extraction of Olive leaves 
10 grams of olive leaves powder were macerated in 100 ml of 80% ethanol for 4 
hours at 40
o
C. The extracts were then filtered through a Whatman No.1 filter (Whatman, 
UK) to separate the coarse particles from the solution. The filtrate was then evaporated at 
room temperature under vacuum by using rotary evaporator. The concentrated extract was 
stored in a refrigerator at (2-4°C) until used. 
3.5 Extraction of Thyme oil by steam distillation 
3.5.1 Water Distillation 
This is the simplest and the most cost - effective distillation method. The plant 
material is immersed in water and boiled. The steam and oil vapor are condensed and the 
oil is separated from the water. This method is suitable for flower blossoms and finely 
powdered plant material. 
The distillation temperature should be about 100°C. Care needs to be taken to prevent the 
plant material being damaged by contacting the overheated still walls. The pressure in the 
still should be atmospheric. The distillation time depends on the plant material being 
processed. Prolonged distillation produces only a small amount of extra oil, but does add 
unwanted high boiling compounds and oxidation products. 
3.5.2 Procedure 
A specific amount of dried or fresh plant material:  thyme (500 g) was placed in the 
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steam distillation apparatus, and then the instrument is turned on where steam of boiling 
water is used for extraction of essential oils from the sacs of the plant materials. The steam 
which contains the essential oil is passed through a cooling system to be condensed into a 
liquid from where the essential oil and water are then separated. 
The hydrosol (mixture of oil and water) will be tested for its antibacterial effectiveness and 
for its use as preservative (preservative effectiveness test).   
 
3.6 Preparation of some pharmaceutical dosage forms containing 
Oleuropein, OLE and thyme oil: 
3.6.1 Preparation of Dexamethasone sodium phosphate oral syrup 
Label claim: Each 5 ml contains 0.658 mg of Dexamethasone sodium phosphate / 5ml. 
Table (3.4) Illustrates the general formula for Dexamethasone sodium phosphate oral 
syrup where the function of each component is indicated. 
Function   Qty. /100 ml Component  No. 
Active ingredient 0.013g Dexamethasone sodium phosphate 1 
Flavor 0.1025g Cherry flavor 2 
Coloring agent  5.25 mg Red color 3 
Chelating agent 0.1g Titriplex 4 
Sweetening agent 0.033g Saccharin Sodium 5 
Sweetening agent 50 g Sucrose 6 
Preservative 0.6 g or 0.4 g Oleuropein or OLE 7 
Co solvent 2.6 g Glycerin 8 
Solvent q.s 100 ml Distilled water 9 
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Method of preparation 
1. Transfer 2 liter of purified water at 50oC to the mixing tank. 
2. Mix at 1200 rpm for 4 minutes with manual circulation. 
3. Transfer the sugar to the mixing tank gradually with mixing at 1200 rpm for 15 min 
till  complete dissolving 
4. Transfer the glycerin to the mixing tank .then  mix for 2 min  
5. Add oleuropein to the mixing tank 
6. Dissolve Titriplex in 50ml purified water transfer to the mixing tank and mix for 5 
minutes. 
7. Dissolve red color in 50ml  purified water transfer to the mixing tank and mix for 5 
minutes 
8. Dissolve Saccharin Sodium in 50ml  purified water transfer to the mixing tank and 
mix for 5 minutes 
9. Make up to volume (3.8 liter) with purified water and mix for 5 minutes. 
10. Cool the preparation to be less than 35oC 
11. Add cherry flavor and mix for 1 minute  
12. Dissolve Dexamethasone sodium phosphate in 200ml cold purified water 
13. Transfer to the mixing tank and mix for 5 minutes, with circulation. 
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3.6.2 Preparation of Sodium chloride Nasal spray 
Label claim: Each 10 ml contains 0.074mg of Sodium chloride / 10 ml  
Table (3.5) illustrates the general formula for Sodium chloride Nasal spray where the 
function of each component is indicated. 
 
Method of preparation 
1. Disinfectant the preparation area with suitable disinfecting agent before 
preparation. 
2. Transfer 2liter of purified water to main mixing vessel then heat to about 70oC. 
3. Add oleuropein to main mixing vessel and mix for 5 minutes using fast agitator at 
speed=1500rpm 
4. Add Cremophor RH40 (polyoxyl40 hydrogenated castor oil) to main mixing vessel 
and mix for 5 minutes using fas 
5. t agitator at speed=1500rpm 
 
.Function  Qty. /100 ml Component  No. 
Active ingredient 0.74 g Sodium chloride  1 
Preservative 0.4 g Oleuropein 2 
Preservative 0.1g Thyme oil 3 
Surfactant 1g Cremophor RH40 (Polyoxyl 40 
hydrogenated castor oil) 
4 
Chelating agent 0.06 g EDTA 5 
Buffering agent 0.22 g Sodium dihydrogen phosphate 6 
Buffering agent 0.72 g dibasic sodium phosphate 7 
Solvent 100 ml purified water 8 
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 Dissolve EDTA in about 200ml of 
purified water at about 70 C, then incorporate the solution to main mixing vessel and mix 
for two minutes using fast agitator at 1500 rpm speed. 
6. Add Sodium chloride to main mixing vessel and mix using fast agitator at speed = 
1500rpm until dissolved (about 5 minutes). 
7. Add Sodium dihydrogen phosphate to main mixing vessel and mix for 5 minutes 
using fast agitator at speed=1500rpm. 
8. Add dibasic sodium phosphate to main mixing vessel and mix for 5 minutes using 
fast agitator at speed=1500rpm. 
9. Cool the preparation to less than 35oC. 
10. Make up to volume (4 liter) with purified water and mix for 5 minutes using fast 
agitator at speed=1500rpm. 
3.6.3 Preparation of vitamin D3 Oral drops 
Label claim: Each 10 ml contains 3.485 mg of vitamin D3 crystals / 10 ml 
Table (3.6) illustrates the general formula for vitamin D3 oral drops where the 
function of each component is indicated. 
Function  Qty. /100 ml Component  No. 
Active ingredient 0.03485 g vitamin D3 crystals 1 
Emulsifier 2.5  g Tween 80 2 
Preservative 65  g Glycerin 3 
pH adjustment 0.1 g citric acid andydrous 4 
Antioxidant and 
preservative 
0.4 g Oleuropein 5 
Antioxidant and 
preservative 
0.2 g Thyme oil 6 
Flavor 3.325 mg Orange oil flavor 7 
Vehicle 100 ml Purified water 8 
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Method of preparation 
1. Turn off  fluorescent light and use the sodium lamp 
2. Transfer tween 80 to mixing tank 
3. Add vitamin D3crystals and mix until completely dissolved for about 45 minutes 
4. Transfer vitamin D3 crystals and Tween 80 mixture to the mixing tank. 
5. Add glycerin to the above mixture and mix for about 15 minutes using mixing heat. 
6. Dissolve oleuropein in orange oil flavor, transfer the mixture to the mixing tank and 
mix for 5 minutes 
7. Dissolve citric acid anhydrous in 200ml purified water. 
8. Add citric acid solution to the mixing tank, and mix for 5 minutes. 
9. Make up to volume (4 liter) with purified water. 
10. Mix the whole tank for 10 minutes by using mixing heater 
3.7 Chemical and physical analytical Test Methods: 
3.7.1 Determination of oleuropein 
Determination of oleuropein in pharmaceutical preparations, reversed -  phase 
HPLC method was used with silica-based C18 bonded phase column (C18, 250mm × 4.6 
ID) with mobile phase consisting of a mixture of water and acetonitrile (80/20 volume 
ratio) containing 1% acetic acid at a flow rate of 1.0 mL/min. UV detector at 237 nm was 
used for oleuropein determination. The injection volume used is 20.0 µl for both standard 
and sample solutions. Identification of oleuropein in olive leaves extracts was based on 
retention times in comparison with standard of oleuropein. The quantitation was carried 
out using the external standard method. The concentration of oleuropein was calculated 
using peak area and the calibration curves obtained from oleuropein standard solution. 
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3.7.2 Determination of Dexamethasone sodium phosphate 
For determination of Dexamethasone sodium phosphate from formula syrup, 
reversed phase HPLC method was used with column: (RP- select B,125Xmm,5um) mobile 
phase consisting of a mixture of methanol and acetonitrile (40/60 volume ratio) containing 
1% acetic acid at a flow rate of 1.2 mL/min. UV detector at 240 nm was used for 
Dexamethasone sodium phosphate determination. The injection volume used is 20.0 µl for 
both standard and sample solutions. Identification of Dexamethasone sodium phosphate 
from formula syrup was based on retention times in comparison with standard of 
Dexamethasone sodium phosphate. The quantitation was carried out using external 
standard method. The concentration of Dexamethasone sodium phosphate was calculated 
using peak area and the calibration curves obtained from standard solution. The amount of 
Dexamethasone sodium phosphate was expressed as milligram per gram 5 ml of formula 
syrup. 
 
3.7.3 Determination of Sodium chloride 
        Reagent: 
a) adsorption indicator  - dissolve 50mg of eosin y in 10 ml of water         
b) glacial acetic acid and methanol,  
c) 0.05 N silver nitrate:  dissolve about 2.124 g of silver nitrate in 250 ml of water 
d) standardize the solution as follows: 
  Transfer about 100 mg, accurately weighed, of reagent grade Sodium chloride, 
previously dried at 110 C for 2 hours to a 100-ml beaker and dissolve in 5 ml of water. 
Add 5 ml of acetic acid, 50 ml of methanol, and about 0.5 ml of Eosin and stirr, preferably 
with a magnetic stirrer, and titrate with the silver nitrate solution. 
The concentration of sodium chloride in the pharmaceutical product was determined by 
titration using standardized silver nitrate solution. 
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3.7.4 Determination of vitamin D3  
Determination of vitamin D3 from formula, reversed phase HPLC method was used 
with column (RP18e, 150 - 4.6 mm,5µm) with mobile phase consisting of a mixture of 
methanol and acetonitrile (25/75 volume ratio) containing 1% acetic acid at a flow rate of 
1.2 mL/min. UV detector at 268 nm was used for vitamin D3 crystals determination. The 
injection volume used is 20.0 µl for both standard and sample solutions. Identification of 
vitamin D3 from formula was based on retention times in comparison with standard of 
vitamin D3 crystals. The quantitation was carried out using external standard method. The 
concentration of vitamin D3 crystals was calculated using peak area and the calibration 
curves obtained from vitamin D3 crystals standard solution. The amount of vitamin D3 
crystals was expressed as milligram per ml of formula. 
3.7.5 Determination of PH 
Determination of the prepared formula was measured using pH meter (pH meter             
211R Hanna).  Calibrate the pH meter electrode between pH 4.0 and 7.0 in case the 
product pH is below 7.0, or calibrate the pH meter electrode between pH 7.0 and 9.0  in 
case the product pH is above 7.0. Immerse the electrode into the product and document the 
reading after stabilization. Repeat the measurement three times and calculate the average 
of readings.                                                                                      .   
3.8 Microbiological Test methods  
3.8.1 Antimicrobial Effectiveness Testing 
This procedure is designed to evaluate the antimicrobial effectiveness of 
antimicrobial preservatives used in Oral products made with aqueous base or vehicles 
3.8.1.1 General instructions  
 Prepare the agar media to be ready for use, in a liquid form at 45oC. 
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 The bacterial and yeast suspensions are to be used within 2 hours of harvest 
otherwise refrigerate the suspension for 24 hrs. , while the fungal preparation may 
be stored under refrigeration for up to 7 days. 
 Work aseptically under laminar flow for all the preparations. 
 
3.8.1.2 Media: 
For the cultivation of the test organisms, select agar medium that is favorable to the 
rigorous growth of the respective stock culture. The recommended media are Soybean 
Casein Digest Agar/Broth and Sabouraud’s Dextrose Agar/Broth. Add a suitable 
inactivator (neutralizer) for the specific antimicrobial properties in the product to the broth 
and/or agar media used for the test procedure if required.  
 
3.8.1.3 Growth promotion of the media 
  Media used for testing needs to be tested for growth promotion by inoculating the 
medium with appropriate microorganisms.  It is preferable that test microorganisms be 
chosen for growth promotion testing (Section 3.8.1.5).  
Solid media tested for growth promotion is to be set up using pour plate method in order to 
determine a microbial plate count (CFU) which must be ≥ 70% of the microorganism 
inoculum’s calculated value. 
3.8.1.4 Test organisms: 
All cultures must be no more than 5 passages removed from the original stock culture.  
a. Candida albicans (ATCC # 10231) 
b. Aspergillus niger (ATCC # 16404) 
c .Escherichia coli (ATCC # 8739) 
d. Pseudomonas aeruginosa (ATCC # 9027) 
e .Staphylococcus aureus (ATCC # 6538) 
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3.8.1.5 Preparation of inoculums 
1. Preparatory to the test: 
 The surface of a suitable volume of solid agar medium is inoculated from a recently 
revived stock culture of each of the specified microorganisms.  
 Culture conditions for the inoculum preparations are described in Table (3.7). 
Table (3.7) Culture Conditions for Inoculum Preparation: 
 
 
2. Harvesting the bacterial and Candida albicans cultures: 
2.1 The surface growth is washed using sterile saline TS.  
2.2 The suspension is collected in a suitable vessel 
2.3 Sufficient sterile saline TS was added to obtain a microbial count of about 1x10
8
 CFU 
per mL. 
2.4 The number of cells was counted by measuring the turbidity using a spectrophotometer 
at 650 nm to obtain an optical density (O.D.) of:  
Organism 
Suitable 
Medium 
Incubation 
Temperature 
Inoculum 
Incubation 
Time 
Microbial 
Recovery 
Incubation Time 
Escherichia coli 
ATCC No. 8739 
SCD, SCDA 32.5 + 2.5
o
C 18 – 24 hours 3 – 5 days 
Pseudomonas aeruginosa 
ATCC No. 9027 
SCD, SCDA 32.5 + 2.5
o
C 18 – 24 hours 3 – 5 days 
Staphylococcus aureus 
ATCC No. 6538 
SCD, SCDA 32.5 + 2.5
o
C 18 – 24 hours 3 – 5 days 
Candida albicans 
ATCC No. 10231 
SAB, 
SABDA 
22.5 + 2.5
o
C 44 – 52 hours 3 – 5 days 
Aspergillus niger 
ATCC No. 16404 
SAB, 
SABDA 
22.5 + 2.5
o
C 6 – 10 days 3 – 7 days 
35 
 
         A. 0.3-0.45 for S. aureus (~1-3 X10
8
 CFU/ ml). 
         B. 0.2-0.3 for P. aeruginosa and E. coli (~1-3 X10
8
 CFU/ ml). 
C. < 1.0 for C. albicans (~ 1-3 x 10
8
 CFU / ml) 
    2.5. Several dilutions were made (10
-3 – 10-6) and cultivated by pour plate method (1ml 
from each dilution in Sabouraud Dextrose Agar, in duplicates) 
    2.6. Bacteria was inoculated for 24 hours at 35
o
C± 2, and C. albicans at 23
o
C± 2 for 2-3 
days and the CFUs were counted (count plates having between 30-100 CFU). 
3. Harvesting the Aspergillus Niger cultures: 
 3.1 The surface growth was washed using a sterile saline TS containing 0.05% of 
polysorbate 80 & Collected in a suitable vessel 
3.2 A sufficient sterile saline TS was added to obtain a microbial count of about 1x10
8
 
CFU per mL. 
3.3 Several dilutions  were made (10
-3 – 10-8) and seeded by pour plate method (1ml from 
each dilution in Sabouraud Dextose Agar, in duplicates) 
 3.4Cultures were incubated between 2-4 days at 23 ± 2
o
C and the CFUs were counted 
(count plates having between 10-100 CFU). 
4. To determine the number of CFU per mL in each suspension, use the condition of 
media and microbial recovery incubation times listed in Table (3.2) to confirm the initial 
CFU per mL estimate. (This value serves to calibrate the size of inoculum used in the test) 
 
3.8.2 Procedure 
  The procedure requires that the test be conducted with a suitable volume of 
product. It is advisable to begin with at least 20 mL of product. Use the original product 
containers whenever possible or five sterile, capped bacteriological containers of suitable 
size into which a suitable volume of product has been transferred. If the diluted product 
exhibits antimicrobial properties, specific neutralizers may need to be incorporated into the 
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diluents or the recovery media. For purposes of testing, products have been divided into 
two categories: 
b) Category 1 products: Dexamethasone Sodium Phosphate Oral syrup and Vitamin D3   
Oral Drops 
 
Test Procedure for Category Oral Products: 
1. The tested reagent was conducted in 5 original containers (if sufficient volume of 
product is available in each container and the product container can be entered 
aseptically- (i.e. needle and syringe through an elastomeric rubber stopper) or in five 
sterile, capped bacteriological containers of suitable size into which a sufficient volume 
of product has been transferred. 
2.  Each container was inoculated with one of the prepared and standardized inocula, and 
mixed: 
 The initial concentration of viable microorganisms in each test preparation is 
estimated based on the concentration of microorganisms in each of the standardized 
inoculum as determined by the plate-count method. 
 The volume of the suspension inoculum used is between 0.5% and 1% of the 
volume of the product (for example: if volume tested is 20 ml, then inoculated 
volume shall be 100   to 200 l). 
 The concentration of test microorganisms that is added to the product shall reach a 
final concentration in the test preparation after inoculation between 1x10
5
 and1x10
6 
CFU per mL of the product (For example, when 100 to 200l inoculum of 1x108 
CFU/ ml are inoculated in 20ml sample, the final concentration will be 0.5 to 1x10
6 
CFU/ ml respectively). 
3. The inoculated containers were incubated at 22.5 + 2.5oC by UNIMAX 1010 shaker / 
incubator 1000 and of 32.5 + 2.5
o
C by UNIMAX 1010 shaker / incubator 1000. 
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4. A sample was obtained from each container at the appropriate intervals. 
5. Any changes observed in appearance at these intervals were recorded. 
6. The numbers of CFU present in each test preparation for the applicable intervals were 
determined by the plate-count method. 
7.  An inactivator (neutralizer) of the specific antimicrobial was incorporated or the 
product was diluted 1:10, 1:20. . . . 1:100 using sterile purified water in order to 
determine the effective point of preservative in the plate count or in the appropriate 
dilution prepared for plating. These conditions are determined in the validation study of 
the sample based upon the conditions of media and microbial recovery incubation times 
listed in Table 2 (7, 14 and 28 days-refer to Table (3.2) in attachments). 
8. Using the calculated concentrations of CFU per mL present at the start of the test, the 
change in log10 values of the concentration of CFU per mL for each microorganism at 
the applicable test intervals was calculated, and the changes in terms of log reductions 
was expressed (The log reduction is defined as the difference between the log 10 unit 
value of the starting concentration of CFU/ml in the suspension and the log 10 unit 
value of CFU/ml of the survivors at that time point). 
 
c) Category 2 products: Sodium Chloride Nasal Spray Proceed as directed in Category 
Dexamethasone Sodium Phosphate Oral syrup and Vitamin D3 Oral Drops products 
to obtain a concentration of microorganisms in the inoculum between 1X10
-5
 and 
1X10
-6
  CFU per mL of the product. 
 
3.8.3 Interpretation 
The criteria for microbial effectiveness are met if the specified criteria are met, see table 
below. No increase is defined as not more than 0.5 log10 unit higher than the previous 
value measured 
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Category 1 products:  
Not less than a 1.0 log reduction from the initial count at 14 
days, and no increase from the 14day count at 28 days 
Bacteria 
No increase from the initial calculated count at 14, and 28 days. Yeast and Molds 
 
Category 2 products:  
Not less than a 2.0 log reduction from the initial count at 14 
days, and no increase from the 14day count at 28 days 
Bacteria 
No increase from the initial calculated count at 14, and 28 days. Yeast and Molds 
 
3.8.4 Total Aerobic Microbial Count for Liquid Dosage form of Finished Products: 
The purpose of these tests is to test the qualitative and quantitative estimation of total 
viable aerobic count of microorganisms in finished liquid dosage forms . 
3.8.4.1 these tests are applicable to: 
 Non-sterile liquid pharmaceutical preparations as syrups. 
 All liquid forms requiring testing for Escherichia coli, Pseudomonas aeruginosa, 
Salmonella, Staphylococcus aureus, as well as yeasts and molds. 
 
3.8.4.2 General instructions 
a) For Liquids: Perform the test directly. 
b) Test controls: At the time of the test, perform, buffer/broth negative controls, and media  
 negative controls.  
c) Samples: Use 10 bottles per product sample tested (if volume > 100 ml), or 20 bottles (if  
      volume < 100 ml)/ batch.  
d) Physical inspection should be performed for liquid product: 
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- Seeking for solid particulate contamination (fiber, crystals, turbidity ….. etc) 
- Broken bottles or loose (unscrew) caps.. 
3.8.4.3 Sampling Plan:  
1.  Sampling from finished products: 
These products are sampled by the samplers in their final form, in closed bottles,  
 2. Procedure: 
2.1 Plate Method For Bacterial Count  
Samples were transferred aseptically to sterile bottles as follows: 
a) About 10 ml of specimen were transferred accurately to a sterile bottle & was  
repeated  with another sterile bottle. 
b) 90 ml of SCDM or CDSLP (or phosphate buffer of pH 7.2) were added  in 1 bottle, 
and 90 ml of FLM in the other bottle, so that the final dilution is 1:10. The bottles 
were closed and mixed by swirling the bottle gently. 
c) The SCDM bottle (or CDSLP or phosphate buffer bottle) was opened, and   with a 
sterile pipette  1 ml of the sample was drawn and transferred to a petri dish contains 
already solidified SCDA then the petri dish was covered. This step was repeated 
with another plate  
d) Each plate was rotated gently so that the 1 mL of sample covers all the surface of 
the agar in the plate. 
e) The plates were allowed to settle for at least 10 minutes. 
f) After 10 minutes, using a sterile pipette, the remaining liquid on the agar surface 
was drawn.  
g) The dishes were inverted , and incubated at 35oC for 48-72 hours. 
h) Results were observed and average number of microorganisms was expressed from  
the 2 plates in each case (sample or control) as follows: 
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 If growth: Average number of microorganism in each plate/ml wass registered 
(taking into account the initial dilution 1:10). 
 If no growth:  Result  were expressed  < 10 CFU/ml for a negative result. 
2.2 Plate Method for Total Aerobic Yeast and Molds Count   
a) The same procedure as for bacterial count (section 3.4.5.1) but  Sabouraud Dextrose 
Broth/Agar (Sab.D / SDA) were used instead of  SCDM/ SCDA. 
b) The Sab.D bottle and SDA plates were incubated at 20-25oC for 5-7 days. 
2.3 The Membrane Filtration Method 
 A sterile pipette was used draw 10 mL from each sample bottle (10 bottles/ test) and 
transfer into a sterile 100 ml bottle. 
3.8.2.4.A. Filtration: 
a. Filter the sample preparations through a 0.45 micrometer membrane filter about 
50mm in diameter. 
b. Rinse 3 times with 100 mL portions of the chosen diluent.  
3.8.4.4.B. Total Aerobic Bacterial Count (TABC) and Total Combined Yeasts and 
Molds Count (TYMC) 
1. Sterile blunt-tipped forceps, aseptically remove filter and place it were used on the 
surface of solidified SCDA contained in a petri dish, for the TABC test. 
2. Repeat the procedure and place the other filter was used on the surface of solidified 
SDA contained in a petri dish for the TYMC test. 
3. Repeat the same procedure for a control filter used. 
4. Incubate the SCD plates at 30-35oC for 48-72 hours and the SDA plates at 20-25oC for 
5-7 days. 
5. At the end of the incubation period, count the colonies. 
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6. If no colonies are present, report results as 0 CFU per 10g or 10 mL of the sample. (or 
< 10 CFu 1 g or ml). 
 
3.8.4.4.C. Acceptance criteria for nonsterile finished products (USP/BP) 
Table (3.8): Acceptance criteria for nonsterile finished products (USP/BP) 
Route of 
Administration 
TABC 
(CFU/g or ml) 
TYMC 
(CFU/g or ml) 
Absence of* 
Nasal/Otic/ <200 (10
2
) 
<20 (10
1
) 
<10 
P. aeruginosa, and S. aureus 
Oral Liquids <200 (10
2
) <20 (10
1
) 
E.coli 
 
 
** USP/ BP acceptance criteria interpretation  
- 101 CFu : maximum acceptable count =20 
- 102CFu : maximum acceptable count =200 
- 103CFu : maximum acceptable count =2000 
 
3.9  Stability study 
The stability study was conducted for the pharmaceutical formulations  
(Dexamethasone Sodium Phosphate Oral Syrup and Vitamin D3 Oral Drops and Sodium 
Chloride Nasal Spray),  which contain natural substances (oleuropein and thyme oil) as 
well as for the positive control formulation. 
Further experiments were conducted at end of each month for three months, antimicrobial 
tests and Physical parameters such as color, pH, and Precipitation, drug content, 
determination of the content of the natural substance oleuropein by HPLC at the end of 
each month for three months on accelerated conditions(40 ± 2 ° C / 75% ± 5% RH) 
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Chapter Four  
ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ 
 Results & Discussion 
4.1 Growth promotion of the media 
The results of the growth promotion test showed that all the materials (Sabouraud 
Dextrose Agar and Soybean Casein Digest and Sabouraud Medium and Soybean Casein 
Digest Medium) effective on microorganism used in the study and correspond to the sop 
system see table (4.1 - 4.4) 
Table (4.1) Growth promotion of the Sabouraud Dextrose Agar 
Medium : Sabouraud Dextrose Agar 
 
Test Done  Manufacturer Specifiations  Test Result 
Appearance of Dehydrated medium Light beige, free flowing 
and homogenous. 
Complies 
Solubility/color of solution 6.5% solution, soluble in 
distilled water or deionized 
water on boiling .solution is 
light to medium amber 
without precipitate  
Complies 
Appearance of prepared Medium  light to medium amber, 
slightly Opalescent without 
precipitate 
Complies 
PH : at 25 
o
C 5.6 + 0.2 5.8       (pass) 
Culture Response/ growth promotion 
test 
(Microorganism/ATCC/Incubation 
time) 
    
 
10
1
  10
2
 10
3
 
1) C. albicans 
10231/3 day  
490 >1000 >1000 
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2) As. Niger 16404/ 
5 days 
0 3 50 
 
 
Table (4.2) growth promotion of the Soybean Casein Digest Agar 
 
Medium : Soybean Casein Digest Agar 
 
Test Done  Manufacturer 
Specifications  
Test Result 
Appearance of Dehydrated medium Light beige, free flowing 
and homogenous. 
Complies 
Solubility/color of solution 4% solution, soluble in 
distilled water or 
deionized water on boiling 
.solution is light to 
medium amber slightly 
Opalescent. 
Complies 
Appearance of prepared Medium  Light amber, slightly 
Opalescent with no 
significant precipitate. 
Complies 
PH : at 25 
o
C 7.3 + 0.2 7.2          (pass) 
Culture Response/ growth 
promotion test 
(Microorganism/ATCC/Incubation 
time) 
 101  102 103 
S. aureus / 18-24 hrs 30 394 >1000 
E.coli / 18-24 hrs 10 137 >1000 
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Table (4.3) growth promotion of the Sabouraud Medium 
 
Sabouraud Medium  
Test Done  Manufacturer 
Specifications  
Test Result 
Appearance of Dehydrated medium Light beige, free flowing 
and homogenous. 
Complies 
Solubility/color of solution 6.5% solution, soluble in 
distilled water or 
deionized water on boiling 
.solution is light to 
medium amber without 
precipitate  
Complies 
Appearance of prepared Medium   Very light amber,slightiy 
Opalescent without 
precipitate 
Complies 
PH : at 25 
o
C 5.6  + 0.2 5.7      (pass) 
Culture Response/ growth 
promotion test 
(Microorganism/ATCC/Incubation 
time) 
 10
1
  10
2
 10
3
 
As. Niger / 18-24 hrs turbid turbid Turbid 
C. albicans /18 -24 hrs turbid turbid turbid 
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Table (4.4) growth promotion of the Soybean Casein Digest Medium 
 
Medium : Soybean Casein Digest Medium  
Test Done  Manufacturer 
Specifications  
Test Result 
Appearance of Dehydrated medium Light beige, free flowing 
and homogenous. 
Complies 
Solubility/color of solution 3% solution, soluble in 
distilled water or 
deionized water on boiling 
.solution is light amber , 
clear 
Complies 
Appearance of prepared Medium  light amber , clear Complies  
PH : at 25 
o
C 7.3+ 0.2 7.5   (pass) 
Culture Response/ growth 
promotion test 
(Microorganism/ATCC/Incubation 
time) 
 10
1
  10
2
 10
3
 
S. aureus  / 48 hrs turbid turbid Turbid 
C. albicans/ 48 hrs turbid turbid turbid 
 
4.2 Antimicrobial Effectiveness Testing: 
To use oleuropein and olive leaves extract (OLE) as preservative in pharmaceutical 
syrup, first antimicrobial activity of samples of oleuropein and OLE was tested at different 
concentrations using distilled water as solvent. (0.2, 0.4 and 0.6% w/v) of oleuropein was 
tested while (0.2, 0.3 and 0.4% w/v) of OLE was used. Tables 1-6 show antimicrobial 
activities of oleuropein and OLE samples at different concentrations. 
In this test, three types of bacteria, one yeast and one fungus (mold) were tested for 
antimicrobial activity of oleuropein and olive leaves extract. Bacteria Includes one gram 
positive (Staphyloccus aureus,(ATCC NO. 6538)) and two gram negative (Pseudomonas 
aeruginosa(ATCC 9027)), and (Escherichia coli , (ATCC NO. 3739) while Candida 
albicans (yeast)  (ATCC NO.10231) and Aspergillus niger (mold) (ATCC NO. 16404) 
were used in this test which are examples of fungi that can cause infections in human body. 
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4.3 Oleuropein 
Using 0.2% w/v oleuropein, results showed that there is more than 1 log reduction 
(10 folds) in the counts (CFU) of the three bacteria tested from the initial count at 14 days 
(for Staphyloccus aureus there is complete inhibition after 7, and 14 days of incubation at 
all dilution used, the same for Pseudomonas aeruginosa where more than 10 fold (1. Log) 
reduction in counts after 7 and 14 days using all dilutions, same results (as for 
Pseudomonas aeruginosa) were obtained for Escherichia coli, and there is complete 
inhibition of these three bacterial strains after 28 days (i.e. no increase from the 14 days 
count to 28 days (see Table 4.1). So this implies that 0.2% w/v oleuropein can be used as 
antimicrobial agent against these three types of bacteria. But to be used as preservative, the 
compound (potential preservative) should be also effective against yeast and mold in 
addition to those three types of bacteria mentioned above. However at 0.2% w/v 
oleuropein, there is increase in the count of yeast (Candida albicans) and 
fungus(Aspergillus niger) from the initial (time zero) at 14 days, which indicates that 
oleuropein at this concentration cannot be used as preservative since it is not effective 
against yeast and mold (see table 4.1) but it can be used as antimicrobial against the three 
types of bacteria mentioned above. So this leads us to increase the concentration to (0.4% 
w/v) At this concentration, oleuropein was found to be effective against the three bacteria 
(as 0.2% concentration) where more than 10 fold reduction in the counts were obtained at 
14 days and no increase in the counts after 28 days. Regarding its activity against yeast and 
mold, results showed that it is (as 0.2% w/v) not effective against yeast and mold, (Table 
4.2). Increasing the concentration of oleuropein to 0.6% resulted in complete inhibition of 
all three bacteria strains after 7, 14 and 28 days, and no increase in the yeastand mold 
counts from initial time at 14 and 28 days, (see Table 4.3). This result indicates that (0.6% 
w/v) oleuropein is a good concentration to be used as preservative. 
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Table (4.5). Antimicrobial activity of oleuropein (0.2%  w/v) in distilled water against 
three types of bacteria, one yeast and one mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATC
C 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 >103    406 1201 >103 >103 
>>103
.. 0  
6538 
 
S. aureus 1748 >103    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 260 180   133 546 >103 >103 >>103 0  
9027 
 
P. aeroginosa 1270 >103    0 61 251 717 >103 7 
440 >103    0 0 10 29 103 14 
 375 >103   0 0 0 0 0 28 
 32 449   511 1118 >103 >103 >>103 0 
 
8739 
 
 
E.coli 
>103 >103    12 76 291 870 >103 7 
597 >103    0 0 0 29 100 14 
100 912    0 0 0 0 0 28 
 28 115 928  509 1301 >103 >103 >103 0 
 
10231 
 
 
 
C. albicans 
 
145
0 
>103   477 1533 >103 >103 >103 7 
 >103 >103   142 1023 >103 >103 >103 14 
 
126
9 
   181 208 1230 >103 >103 28 
 5 69 484 >103 9 3 660 >103 >>103 0 
 
16404 
 
A. Niger  1 6 90  5 51 129 511 >103 7 
 1 4 28  4 39 316 1515 >103 14 
 2 10 66  0 12 41 380 >103 28 
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Table (4.6). Antimicrobial activity of oleuropein (0.4% w/v)  in distilled water against three 
types of bacteria, one yeast and one mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATC
C 
NO. 
Microorganism 
10
6
  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   386 1175 >103 >103 >>103.. 0  
6538 
 
S. aureus 
1748 >103    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   98 348 >103 >103 >>103 0  
9027 
 
P. aeruginosa 
1270 >103    0 7 41 280 1416 7 
440 >103    0 0 0 0 0 14 
 375 >103   0 0 0 0 0 28 
 32 449   336 1029 >103 >103 >>103 0  
8739 
 
 
E.coli 
>103 >103    4 30 187 636 >103 7 
597 >103    0 0 0 0 0 14 
100 912    0 0 0 0 0 28 
 28 115 928  11 111 820 >10
3 >>103 0  
10231 
 
 
 
C. albican 
 1450 >103   318 1168 >103 >103 >>103 7 
 >103 >103   63 921 >103 >103 >103 14 
 1269    75 176 1056 >103 >103 28 
 5 69 484 >103 4 77 529 >103 >>103 0  
16404 
 
A.niger 
 1 6 90  2 28 104 300 >103 7 
 1 4 28  3 18 208 1220 >103 14 
 2 10 66  0 1 13 233 577 28 
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Table (4.7) Antimicrobial activity of oleuropein (0.6% w/v) in distilled water against three types of 
bacteria, one yeast and one mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10
6
  CFU/ml 
10-
6 
10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   87 541 >103 >103 >103.. 0 
 
6538 
 
S. aureus 
174
8 
>10
3    0 0 0 0 0 7 
838 
>10
3    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   3 28 291 >103 >103 0 
 
9027 
 
P. aeruginosa 
127
0 
>10
3    0 2 8 62 779 7 
440 
>10
3    0 0 0 0 0 14 
 375 
>10
3   0 0 0 0 0 28 
 32 449   51 577 >103 >103 >103 0 
 
8739 
 
 
E.coli 
>10
3 
>10
3    6 13 94 416 >10
3 7 
597 
>10
3    0 0 0 0 0 14 
100 912    0 0 0 0 0 28 
 28 115 928  12 100 633 >103 
>>10
3 
0 
 
10231 
 
 
 
C. albican 
 
145
0 
>10
3   327 1114 >10
3 >103 >103 7 
 
>10
3 
>10
3   12 155 514
 640 770 14 
 
126
9 
   0 2 70 539 440 28 
 5 69 484 
>10
3 3 34 270 >10
3 >103 0 
 
16404 
 
A. Niger  1 6 90  0 0 3 45 324 7 
 1 4 28  0 0 2 21 150 14 
 2 10 66  0 0 6 16 230 28 
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4.4 Olive leaves extract 
The same tests were repeated using OLE instead of oleuropein at three 
concentrations (0.2, 0.3, and 0.4% w/v). At (0.2% w/v) OLE, results showed that it is 
effective against the three bacteria tested but not effective against yeast and mold (Table 
4.4). Increasing the concentration to (0.3% w/v) OLE did not give the desired activity 
against yeast and mold (Table 4.5), which guides us to increase the concentration to (0.4% 
w/v) which resulted in a good activity against the three bacteria as well as yeast and mold 
(Table 4.6). So this implies that OLE at this concentration can be used as the preservative 
in pharmaceutical syrup. 
Comparison between oleuropein and OLE 
It is interesting to compare oleuropein with OLE in terms of antimicrobial activity. 
Referring to tables 1- 6, it is clear that OLE is more effective compared to oleuropein till 
(0.4% w/v) of OLE is sufficient to be used as preservative compared to (0.6% w/v) 
oleuropein. This may be attributed to additional active compounds (e.g. polyphenolic and 
flavonoids) in OLE which may have such activity or have synergistic activity. 
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Table (4.8). Antimicrobial activity of OLE (0.2% w/v) in distilled water against three 
types of bacteria, one yeast and one mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   481 1315 >103 >103 >>103.. 0  
6538 
 
S. aureus 
1748 >103    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   213 611 >103 >103 >>103 0  
9027 
 
P. aeruginosa 
1270 >103    0 21 101 491 1515 7 
440 >103    0 0 0 0 0 14 
 375 >103   0 0 0 0 0 28 
 32 449   215 1316 >103 >103 >>103 0  
8739 
 
 
E.coli 
>103 >103    55 51 714 551 >103 7 
597 >103    0 0 9 42 90 14 
100 912    0 0 0 0 0 28 
 28 115 928  109 355 1114 >103 >103 0  
10231 
 
 
 
C. albican 
 1450 >103   501 1490 >103 >103 >103 7 
 >103 >103   555 1115 >103 >103 >103 14 
 1269    301 521 >103 >103 >103 28 
 5 69 484 >103 30 196 833 >103 >103 0  
16404 
 
A.niger 
 1 6 90  12 55 216 517 >103 7 
 1 4 28  55 56 409 1515 >103 14 
 2 10 66  0 5 31 455 617 28 
52 
 
 
 
 
 
 
 
 
Table (4.9). Antimicrobial activity of OLE (0.3% w/v) in distilled water against three types of 
bacteria, one yeast and one mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   491 1466 >103 >103 >103.. 0  
6538 
 
S. aureus 1748 >10
3    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   221 531 >103 >103 >103 0  
9027 
 
P. aeruginosa 1270 >10
3    15 76 312 741 1516 7 
440 >103    0 0 6 30 93 14 
 375 >103   0 0 0 0 0 28 
 32 449   215 1312 >103 >103 >103 0  
8739 
 
 
E.coli 
>103 >103    13 69 719 551 >103 7 
597 >103    0 0 5 24 135 14 
100 912    0 0 0 0 0 28 
 28 115 928  33 152 1954 >100 >103 0  
10231 
 
 
 
C. albican 
 1450 >103   519 1461 >103 >103 >103 7 
 >103 >103   122 1201 >103 >103 >103 14 
 1269    175 221 >103 >103 >103 28 
 5 69 484 >103 12 122 711 >103 >>103 0  
16404 
 
A.niger  1 6 90  6 47 188 633 >10
3 7 
 1 4 28  55 45 325 1420 >103 14 
 2 10 66  0 5 22 341 716 28 
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Table (4.10). Antimicrobial activity of OLE (0.4% w/v) in distilled water against three types 
of bacteria, one yeast and One mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   79 161 >103 >103 >103.. 0  
6538 
 
S. aureus 1748 >10
3    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   2 21 267 >103 >103 0  
9027 
 
P. aeruginosa 1270 >10
3    0 0 3 43 519 7 
440 >103    0 0 0 0 0 14 
 375 >103   0 0 0 0 0 28 
 32 449   32 435 >103 >103 >103 0  
8739 
 
 
E.coli 
>103 >103    3 11 79 218 >103 7 
597 >103    0 0 0 0 0 14 
100 912    0 0 0 0 0 28 
 28 115 928  9 45 510 >103 >103 0  
10231 
 
 
 
C. albican 
 1450 >103   246 445 760 880 1150 7 
 >103 >103   2 
109 446 776 880 
14 
 1269    0 0 42 408 411 28 
 5 69 484 >103 0 21 185 >103 >103 0  
16404 
 
A. Niger  1 6 90  0 0 2 32 411 7 
 1 4 28  0 0 5 15 132 14 
 2 10 66  0 0 0 8 21 28 
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4.4 Thyme oil 
The same tests were repeated using Thyme oil at (0.1% v/v)concentration. At this 
concentration, results showed that it is effective against the three bacteria only (Table 4.7). 
Mixture of thyme oil at this concentration and oleuropein (0.4% w/v) showed also activity 
against the three bacteria tested and effective against yeast and mold (Table 4.8). This 
implies that thyme oil/oleuropein mixture can be used as natural preservatives in 
pharmaceutical preparations. 
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Table (4.11). Antimicrobial activity of thyme oil (0.1% w/v)  in distilled water against three 
types of bacteria, one yeast and One mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   79 161 >103 >103 >103.. 0  
6538 
 
S. aureus 1748 >10
3    0 0 0 617 821 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   2 21 267 >103 >103 0  
9027 
 
P. aeruginosa 1270 >10
3    0 0 3 43 519 7 
440 >103    0 0 0 0 0 14 
 375 >103   0 0 0 0 0 28 
 32 449   32 435 >103 >103 >103 0  
8739 
 
 
E.coli 
>103 >103    3 11 79 218 >103 7 
597 >103    0 0 0 0 0 14 
100 912    0 0 0 0 0 28 
 28 115 928  290 401 910 >103 >103 0  
10231 
 
 
 
C. albican 
 1450 >103   246 445 860 >103 >103 7 
 >103 >103   62 
109 516 776 880 
14 
 1269    75 202 550 808 901 28 
 5 69 484 >103 623 811 >103 >103 >103 0  
16404 
 
A. niger  1 6 90  172 732 921 >10
3 >103 7 
 1 4 28  390 420 513 355 486 14 
 2 10 66  399 129 500 301 521 28 
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Table (4.12). Antimicrobial activity of oleuropein (0.4%  w/v) and thyme oil (0.1% v/v) in 
distilled water  against three types of bacteria, one yeast and One mold. 
Control dilution 
(without preservative) 
Test dilution Day 
ATCC 
NO. 
Microorganism 
10*6  CFU/ml 
10-6 10-5 10-4 10-3 10-2 10-5 10-4 10-3 10-2 10-1    
 45 577   61 311 >103 >103 >103.. 0 
 
6538 
 
S. aureus 
174
8 
>103    0 0 0 0 0 7 
838 >103    0 0 0 0 0 14 
68 770    0 0 0 0 0 28 
 16 180   5 31 215 >103 >103 0 
 
9027 
 
P. aeruginosa 
127
0 
>103    0 0 9 23 419 7 
440 >103    0 0 0 0 0 14 
 375 >103   0 0 0 0 0 28 
 32 449   52 255 >103 >103 >103 0  
8739 
 
 
E.coli 
>103 >103    8 21 99 202 >103 7 
597 >103    0 0 0 0 0 14 
100 912    0 0 0 0 0 28 
 28 115 928  15 58 703 >103 >103 0  
10231 
 
 
 
C. albican 
 1450 >103   346 245 560 820 1150 7 
 >103 >103   8 
109 446 476 810 
14 
 1269    0 0 31 455 411 28 
 5 69 484 >103 0 21 185 >103 >103 0  
16404 
 
A. niger  1 6 90  0 0 2 12 714 7 
 1 4 28  0 0 15 13 162 14 
 2 10 66  0 0 0 6 171 28 
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In order to test the effectiveness of natural substances (oleuropein and OLE) and 
(thyme oil) as natural preservatives and natural antioxidants in pharmaceuticals, three types 
of drugs were used primarily for children to study the possibility of replacing chemical 
preservatives and antioxidants (which are unsafe) especially for children by natural 
substances which are more safe. The pharmaceutical drugs used were Dexamethasone 
Sodium Phosphate Oral Syrup, Sodium Chloride Nasal Spray, and Vitamin D3 Oral drops. 
The natural materials were introduced in accordance with the results of the antimicrobial 
tests. The pharmaceutical syrups were then followed up when the natural materials were 
tested for their effectiveness as preservatives through several tests in the microbiology 
labs. The preparations were also followed up in terms of the proportion and consistency of 
natural materials as well as the stability and proportion of the active materials through 
analysis by HPLC. 
4.5 Use of natural preservatives in pharmaceutical preparations 
In this work, oleuropein and OLE were used in the Dexamethasone Sodium 
Phosphate Oral Syrup pharmaceutical preparation, while oleuropein and thyme oil were 
used in  
Sodium Chloride Nasal Spray, and oleuropein and thyme oil were used in Vitamin D3 Oral 
Drops.                                  
4.5.1 Dexamethasone Sodium Phosphate Oral Syrup with natural preservative 
(oleuropein and OLE) 
The formulation and follow-up of the preparation were done by analyzing and 
testing the ratio of the natural substance oleuropein as a natural preservative. Also, active 
substances (Dexamethasone phosphate) were determined by HPLC and the natural material 
was followed up in the preparation in terms of its effectiveness as antimicrobial for three 
months. The three pharmaceutical drugs were stored at accelerated conditions(40 ± 2 ° C / 
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75% ± 5% RH) to test the stability of the product (concentration of active and natural 
preservative and stability of the drug itself: pH, precipitation, appearance, color). 
By testing the %  of oleuropein by (HPLC) in  Dexamethasone Sodium Phosphate Oral 
Syrup, results showed that oleuropein is stable during three months of storage at  
Accelerated Conditions while the % of oleuropein was 98% at day zero decreased to 97%, 
95%, 94% at 1,2,3 months of storage respectively. The results showed that oleuropein is 
stable in this formula. Chromatogram of Oleuropein standard and sample is shown in 
figure 4.1, 4.2.                                                                                                
The percentage of the active ingredient (Dexamethasone sodium phosphate) for three 
months was 96% at zero days decreased to 94%, 94%, 92% in 1,2,3 months of storage 
respectively (Figure 4.3),where the results indicate that the active substance is stable and 
not affected by the addition of natural materials and the same results for OLE. 
 
 
Figure (4.1): Chromatogram of Oleuropein standard 
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Figure (4.2): Chromatogram of Oleuropein in Dexamethasone Sodium Phosphate Oral 
Syrup, stored at accelerated Condition (40±2 °C /75%±5% RH) for 3 months. 
 
 
Figure (4.3): Chromatogram of (Dexamethasone sodium phosphate in formulate syrup, 
stured at accelerated Condition (40±2 °C /75%±5% RH) for 3 months. 
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4.5.1.2- Effect on pH of Dexamethasone sodium phosphate oral syrup: 
As it is shown in table 1,pH  of Dexamethasone sodium phosphate oral syrup was 
not affected by the addition of oleuropein where very minor decrease in pH was observed, 
still it is in the acceptable range of pH for this product. ( table 4.13) 
Table (4.13): Effect on pH of Dexamethasone sodium phosphate syrup: 
Range pH  (4.5-6) 
pH (Dexamethasone sodium   
phosphate syrup) 
 
5.6 0      Month 
5.6 1       Month 
5.4 2      Month 
5.3 3      Month 
 
4.5.1.3. Antimicrobial test of Dexamethasone sodium phosphate syrup:           
4.5.1.3.1Microbial limit test – Direct transfer (broth media): 
 Microbial test for Dexamethasone sodium phosphate syrup with oleuropein 0.6% w/v 
concentration was conducted for 0,1,2, and 3 months of storage, and compared to the 
positive control (Dexamethasone sodium phosphate with methyl and propylparaben) and 
negative control (Dexamethasone sodium phosphate without any preservative). 
Results showed that there is no bacterial growth using the three media shown in table 
(4.10), which is exactly similar to the result of Dexamethasone sodium phosphate control 
sample (with methyl and propylparaben preservative). This result showed the effectiveness 
of oleuropein as antimicrobial agent. Negative control of Dexamethasone sodium phosphate 
syrup without preservative showed bacterial growth (see table 4.14) 
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Table (4.14): Microbial limit test – Direct transfer (broth media) test for 
Dexamethasone sodium phosphate syrup with oleuropein 0.6% concentration:                                    
 
Results 
Negative control 
No preservative 
Results 
positive control 
 (using methyl and 
propyl paraben) 
Results of sample 
with oleuropein at 
0.6% 
Medium 
Turbid Clear Clear Tryptic soy Broth 
Turbid Clear Clear Fluid lactose medium 
Turbid Clear Clear 
Sabouraud dextrose 
broth 
 
4.5.1.3.2 Microbial limit test –Total count:   
 The total microbial count of Dexamethasone sodium phosphate syrup samples was 
conducted and results (table 4.14) showed that samples with oleuropein is compatible to 
the positive control (Dexamethasone sodium phosphate syrup with methyl and propylparaben 
preservative) for example  the number of bacterial on tryptic soy agar were found to be <10 
CFU  for each type of bacteria which is in accordance with the acceptable  limit ( <200 
CFU). 
The same results were obtained for yeast and mold, where results showed that 
Dexamethasone sodium phosphate syrup samples with oleuropein are close to that with 
convention chemical preservative methyl and propylparaben (Table 4.15). 
Table (4.15): Microbial limit test –Total count test for Dexamethasone sodium phosphate 
syrup with oleuropein 0.6% w/v concentration   
 
Results 
Negative 
control 
CFU/ml 
Results 
positive control 
CFU/ml 
Results 
Sample with 
oleuropein at 0.6% 
CFU/ml 
Limits on agar 
CFU 
#\ml 
Medium 
<180 CFU <10 CFU <10 CFU 
Bacterial 
<200(10
2
)) 
tryptic soy agar 
<10 CFU <10 CFU <10 CFU 
yeasts and molds  
<20  (10
1
) 
sabouraud dextrose 
agar 
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4.5.1.3.3 Microbial limit test – membrane filtration:                  
The number of bacteria on tryptic soy agar was <10 CFU for each type of bacteria, 
and this number is associated with the standard limits (ATCC) which must be <200 CFU.                                                                                  
While yeast and mold colony number on sabouraud dextrose agar was <10 CFU, this 
number is within the standard limits (which should be <20 CFU units), in comparison with 
the product containing natural preservatives sample results, the results of positive control 
were very close. The bacteria, yeasts and mold number in negative control are high 
compared to the positive test preparation and with the product containing natural 
preservatives. (see table 4.16)  
 Table (4.16): Microbial limit test – membrane filtration test for Dexamethasone 
sodium phosphate syrup with oleuropein 0.6% w/v concentration: 
 
4.5.2 Sodium Chloride nasal spray with oleuropein and thyme oil 
In the second formulation, Sodium Chloride nasal spray containing oleuropein 
(0.4% w/v concentration) and thyme oil in the concentration (0.1% v/v). The product is 
formulated with natural preservative instead of the chemical preservative (benzalkonium 
chloride) in sodium chloride The natural materials were also prepared  and tested  for their 
effectiveness against microbes through the tests mentioned previously and tests were 
repeated for the same stored specimen each month(for three months), another formula was 
prepared to without preservatives (negative control). The results of the product containing 
natural preservatives were compared with the preparations (positive control). 
Results 
Negative 
control  test 
CFU/ml 
Results 
positive test 
CFU/ml 
Results 
Sample with 
oleuropein 
0.6% 
CFU/ml 
Limits on agar 
CFU/ml 
Medium 
<120 < 10 <10 
<200(10
2
)) 
Bacteria 
tryptic soy agar 
<20 < 10 <10 
yeasts and molds  
<20  (10
1
) 
Sabouraud dextrose agar 
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By testing the percentage (%) of oleuropein by (HPLC) in (Sodium Chloride Nasal Spray), 
results showed that oleuropein is stable during three months of storage at  Accelerated 
Conditions while the % of oleuropein was 96% of day zero decreased to 95%, 94%, 92% at 
1,2,3 months of storage respectively These results showed that oleuropein is stable in this 
formula. Chromatogram of Oleuropein standard and sample is shown infigure 4.4, 4.5). 
The percentage of the active ingredient (Sodium chloride(NaCl)) for three months by 
titration method was as follows: 97% of zero days decreased to 96%, 95%, 95% in 1,2,3 
months of storage respectively Where the results indicate that the active substance is stable 
and not affected by the addition of natural materials. 
 
Figure (4.4): Chromatogram of Oleuropein standard 
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Figure (4.5): Chromatogram of Oleuropein in Sodium Chloride nasal spray, stored at 
accelerated Condition (40±2 °C /75%±5% RH) for 3 months. 
4.5.2.2 Effect on pH of Sodium Chloride nasal spray: 
As it is shown in table 10, pH of Sodium Chloride nasal spray was not effected by addition 
of oleuropein where very minor decrease in pH was observed ,but still in the acceptable 
range of pH for this product. 
Table (4.17): Effect on pH on Sodium Chloride nasal spray 
Range PH (5-7.5) pH (Sodium Chloride nasal spray) 
6.6 0   Month 
6.6 1       Month 
6.5 2      Month 
6.5 3      Month 
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4.4.2.3 Microbial limit test – 
4.4.2.3.1 Direct transfer (broth media):  
 Microbial test for Sodium Chloride nasal spray with oleuropein 0.4% w/v  and 
thyme oil 0.1% v/v concentration was conducted at 0,1,2, and 3 months of storage, and 
compared to the positive control (Sodium Chloride nasal spray with benzalkonium) and 
negative control (Sodium Chloride nasal spray without any preservative) 
Results showed that there is no bacterial growth using the three media shown in table 
(4.14) which is exactly similar to the result of Sodium Chloride nasal spray control sample 
(with benzalkonium preservative). This result showed that oleuropein and thyme oil are 
effective as antimicrobial agent. Negative control of Sodium Chloride nasal spray without 
preservative showed bacterial growth (Table 4.18) 
Table (4.18): Microbial limit test – Direct transfer (broth media):  
 
4.5.2.3.2- Microbial limit test –Total count:  
The total microbial count of Sodium Chloride nasal spray samples was conducted and 
results (table 1.3.2) showed that samples with oleuropein and thyme oil is compatible to 
the positive control (Sodium Chloride nasal spray with benzalkonium preservative) for 
example the number of bacteria on tryptic soy agar were found to be <10 CFU  for each 
type of bacteria which is in accordance with the acceptable  limit ( <200 CFU). The same 
Results 
Negative control 
(No preservative) 
 
Results 
positive test 
(using benzalkonium 
chloride) 
Sample with 
oleuropein (0.4%) and 
thyme oil (0.1) 
Medium 
Turbid Clear Clear Tryptic soy Broth 
Turbid Clear Clear 
Fluid lactose 
medium 
Turbid Clear Clear 
Sabouraud dextrose 
broth 
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results were obtained for yeast and mold, where results showed that Sodium Chloride nasal 
spray samples with oleuropein are very close to that with convention chemical preservative 
benzalkonium (table 4.19) 
 Table (4.19): Microbial limit test –Total count: 
 
4.5.2.3.3 - Microbial limit test – membrane filtration:  
The number of bacteria in the product containing natural preservatives on tryptic 
soy agar was <10 CFU for each type of bacteria, and this number is associated with the 
standard limits (ATCC) which must be <200 CFU.                                                                                                                                            
While for yeast and mold on Sabouraud dextrose agar the number of colonies in the same 
product were<10 CFU/ml for each type, this number is acceptable compared to the 
standard limits (which should be <20CFU/ml).  
In positive control the number of colonies grown on agar plates for the bacteria, yeast and 
mold are high in comparison with the standard limits and the product containing natural 
preservatives. (See table 4.20)  
 
 
 
 
Results 
Negative 
control  test 
CFU/ml 
Results 
positive test 
CFU/ml 
Sample with 
oleuropein 
(0.4%) and 
thyme oil (0.1) 
CFU/ml 
Limits on agar 
CFU/ml 
Medium 
<120 <10 <10 
<200(10
2
)) 
Bacteria 
tryptic soy agar 
<18 <10 <10 
yeasts and molds  
<20  (10
1
) 
sabouraud dextrose agar 
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Table (4.20): Microbial limit test – membrane filtration:    
 
4.5.3 Vitamin D3 Oral Drops with oleuropein and thyme oil 
In the third formula, oleuropein was used in the concentration (0.4% w/v), and the 
thyme oil used at a concentration of (0.2% v/v) in Vitamin D3 Oral Drops. 
 It was formulated as a natural preservative and also as an antioxidant instead of a chemical 
(Butylhyroxytoluene). The formulation and follow-up of the product were carried out by 
analyzing and testing oleuropein as a natural preservative and also test and analyzing the 
ratio of active ingredient in vitamin D3 by (HPLC). Natural materials were also followed 
in preparation in terms of their effectiveness as antimicrobial agents through tests and had 
for months compared with a positive test in terms of results and also compared with 
negative control test. 
By testing the % of (oleuropein) by (HPLC) in Vitamin D3 Oral Drops, results showed that 
oleuropein is stable during three months of storage at Accelerated Conditions while the % 
of oleuropein was 95% of day zero decreased to 93.7%, 93%, 91.8% at 1,2,3 months of 
storage respectively. These results showed that oleuropein is stable in this formula. 
Chromatogram of Oleuropein standard and sample were shown (see figure 4.6, 4.7) 
Results of 
negative 
control  CFU/ml 
Results 
Positive control  
CFU/ml 
Results 
Sample with 
oleuropein 
(0.4%) and 
thyme oil (0.1) 
CFU/ml 
Limits on agar 
CFU/ml 
 
Medium 
<220 <10 <10 
<200(10
2
)) 
Bacteria 
tryptic soy agar 
<20 <10 <10 
yeasts and molds  
<20  (10
1
) 
Sabouraud dextrose agar 
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The percentage of the active ingredient (vitamin D3) for three months was as follows: 98% 
of zero days decreased to 97%, 95%, 94% in 1, 2, 3 months of storage respectively (Figure 
4.8, 4.9), where the results indicate that the active substance is stable and not affected by 
the addition of natural materials. 
 
Figure (4.6): Chromatogram of Oleuropein standard 
 
Figure (4.7): Chromatogram of Oleuropein in Vitamin D3 Oral Drops,  stored at 
accelerated Condition (40±2 °C /75%±5% RH) for 3 months 
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Figure (4.8): Chromatogram of vitamin D3 standard 
 
Figure (4.9): Chromatogram of vitamin D3 in Vitamin D3 Oral Drops, stored at                      
accelerated Condition (40±2 °C /75%±5% RH) for 3 months 
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4.5.3.2 Effect on pH of Vitamin D3 Oral Drops 
As it is shown in table, pH of Vitamin D3 Oral Drops were not affected by the addition of 
oleuropein where very minor decrease in pH was observed, still it is in the acceptable 
range of pH for this product. 
Table (4.21): Effect on pH on Vitamin D3 Oral Drops 
Range PH ( 2-4) pH (Vitamin D3 Oral Drops) 
3.0 0       Day 
3.1 1       Month 
2.9 2      Month 
2.9 3      Month 
 
4.5.3.3 Microbial limit test  
4.5.3.3.1 Direct transfer (broth media): 
 Microbial test for Vitamin D3 Oral Drops with oleuropein 0.4% w/v  and thyme oil 
0.2% v/v concentration was conducted at 0,1,2, and 3 months of storage, and compared to 
the positive control (Vitamin D3 Oral Drops with glycerin).  
Results showed that there is no bacterial growth using the three media shown in table(4.18) 
which is less than the result of Vitamin D3 Oral Drops control sample (with glycerin 
preservative). This refers to the use of natural substances (oleuropein or thyme oil) with the 
chemical (glycerin) which showed results better than those with the use of (glycerin) only 
(see table(4.22). 
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Table (4.22): Microbial limit test – Direct transfer (broth media):     
Negative control 
No preservative 
Results 
positive test 
(using glycerin) 
Sample with 
oleuropein (0.4%) 
and thyme oil (0.2) 
 
Medium 
Clear Clear Clear Tryptic soy Broth 
Clear Clear Clear Fluid lactose medium 
Clear Clear Clear Sabouraud dextrose broth 
 
4.5.3.3.2 Microbial limit test –Total count and Membrane filtration: 
 The number of bacteria on tryptic soy agar was <10 CFU for each type of bacteria, 
and this number is associated with the standard limits (ATCC) which must be <200 CFU. 
While for yeast and mold on Sabouraud dextrose agar was <10 CFU for each type, this 
number is compared to the standard limits (which should be <20 CFU units), in 
comparison with the positive preparation, the results show that the product containing 
natural preservatives show results that are very close to those obtained from positive test 
preparation. (Table 4.23) 
Table (4.23):  Microbial limit test –Total count and Membrane filtration: 
 
Results 
Negative 
control  
CFU/ml 
Results 
positive 
control 
CFU/ml 
Sample with 
oleuropein 
(0.4%) and 
thyme oil (0.2) 
CFU/ml 
Limits on agar 
CFU 
#\ml 
Medium 
<10 <10 <10 
<200(10
2
)) 
Bacteria 
tryptic soy agar 
<10 <10 <10 
yeasts and molds  
<20  (10
1
) 
Sabouraud dextrose agar 
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4.6 Stability of pharmaceutical preparations 
The results showed that pharmaceutical product (Dexamethasone Sodium 
Phosphate Oral Syrup ) When oleuropein was used at a concentration of 0.6% w/v was 
stable for three months with no Precipitation, appearance and color stable  and pH 
remained within the allowable range (4.5- 6). The active ingredient (Dexamethasone 
sodium phosphate) and oleuropein were within the allowable range. 
However, when the same product was used with (OLE) at a concentration of 0.4% w/v, all 
the results were stable except that after a month of preparation there was some 
Precipitation because some substances (OLE) did not completely dissolve and needed a 
surfactant. As shown in the table (4.24) 
As well as for the pharmaceutical product (Sodium Chloride Nasal spray) where 
oleuropein was used at 0.4% w/v and thyme oil at 0.1% v/v concentration. The results for 
three months were stable. There was no precipitation, appearance and, color stable and pH 
within the permissible range of (7.5 - 6) and active ingredient (sodium chloride (NaCl) and 
(oleuropein) within the allowable range as shown in the table (4.24) 
And also for the third pharmaceutical product (Vitamin D3 Oral Drops ) When oleuropein 
was used, with a concentration of 0.4% w/v and thyme oil at a concentration of 0.2%. v/v 
The results for three months are stable with no Precipitation, appearance, color stable pH 
within the permissible range (2-4), the active ingredient (vitamin D3 crystals) and 
oleuropein within the allowable range. As shown in the table (4.24) 
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Table (4.24): Physical parameters and assay results of pharmaceutical formulations 
Accelerated Condition at (40± 2 °C /75%±5% RH): 
 
Assay of 
Active 
material 
Assay of 
oleuropein 
pH Color appearance Precipitation Time Comparisons 
96% 98% 5.6 Red Uniform Negative 0     day Dexamethas
one Sodium 
Phosphate 
Oral Syrup 
94 % 97% 5.6 Red Uniform Negative 1  Month 
94% 96% 5.4 Red Uniform Negative 2  Month 
92% 95% 5.3 Red Uniform Negative 3  Month 
97% 96% 6.6 Brown Uniform Negative 0    Day Sodium 
Chloride 
Nasal Spray 
95% 95% 6.6 Brown Uniform negative 1  Month 
93% 94% 6.5 brown Uniform negative 2  Month 
92 % 92% 6.5 brown Uniform Negative 3  Month 
98  % 95% 3.0 Golden Uniform negative 0    Day 
 
Vitamin D3 
Oral Drops 
97  % 93.7% 3.1 Golden Uniform negative 1  Month 
95 % 93.% 2.9 Golden Uniform negative 2  Month 
94 % 91.8% 2.9 Golden Uniform Negative 3  Month 
 
4.7 Microbial  stability of pharmaceutical  preparations  
Pharmaceutical preparations were tested in terms of the numbers of bacteria, yeasts, 
and mold. Tryptic soy agar was used as a medium for the bacteria, while Sabouraud 
dextrose agar was used for yeasts and mold. The result was less than < 10 CFU of bacteria, 
yeasts, and mold. The results were close to that of the positive test. The same result was 
obtained for the pharmaceuticals (Sodium Chloride Nasal Spray) and (Vitamin D3 Oral 
Drops).  As shown in the table (4.25).        
Dexamethasone Sodium Phosphate Oral Syrup was also tested using Membrane filtration, 
yeast, and mold. Tryptic soy agar was used, (Sabouraud dextrose agar) for three months. 
The result was less than 10 CFU of bacteria, yeast and  mold. The results were close to that 
of a positive test. The same results were obtained for pharmaceuticals Sodium Chloride 
Nasal Spray and Vitamin D3 Oral Drops as shown in Table (4.25). 
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Table (4.25): Antimicrobial limit test of pharmaceutical syrup formulations at  
accelerated conditions (40±2 °C /75%±5% RH):  
Control test Positive Result Month   
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Chapter Five: Conclusion and Future work 
 
test (Novodexon)  
Control test Positive Result month Type of test 
Dexamethasone Sodium Phosphate Oral Syrup 
Direct 
transfer(broth 
media) 
Turbid Clear Clear 0 
Turbid Clear Clear 1 
Turbid Clear Clear 2 
Turbid Clear Clear 3 
Dexamethasone Sodium Phosphate Oral Syrup 
 
Total count 
 
<10 CFU <10 CFU <10 CFU 0 
<100CFU <10 CFU <10 CFU 1 
<180CFU <10 CFU <10 CFU 2 
<180 CFU <10 CFU <10 CFU 3 
Dexamethasone Sodium Phosphate Oral Syrup 
Membrane 
Filtration 
<10 CFU <10 CFU <10 CFU 0 
<100 CFU <10 CFU <10 CFU 1 
<120CFU <10 CFU <10 CFU 2 
<120 CFU <10 CFU <10 CFU 3 
Sodium Chloride Nasal Spray 
Direct 
transfer(broth 
media) 
Turbid Clear Clear 0 
Turbid Clear Clear 1 
Turbid Clear Clear 2 
Turbid Clear Clear 3 
Sodium Chloride Nasal Spray 
 
Total count 
 
<10 CFU <10 CFU <10 CFU 0 
<80 CFU <10 CFU <10 CFU 1 
<100 CFU <10 CFU <10 CFU 2 
< 120 CFU <10 CFU <10 CFU 3 
Sodium Chloride Nasal Spray 
Membrane 
Filtration 
<10 CFU <10 CFU <10 CFU 0 
<90 CFU <10 CFU <10 CFU 1 
<110 CFU <10 CFU <10 CFU 2 
<220 CFU <10 CFU <10 CFU 3 
Vitamin D3 Oral Drops 
Direct 
transfer(broth 
media) 
Clear Clear Clear 0 
Clear Clear Clear 1 
Clear Clear Clear 2 
Clear Clear Clear 3 
Vitamin D3 Oral Drops 
Total count 
and 
membrane 
filtration 
<10 CFU <10 CFU <10 CFU 0 
<10 CFU <10 CFU <10 CFU 1 
<10 CFU <10 CFU <10 CFU 2 
<10 CFU <10 CFU <10 CFU 3 
76 
 
5.1 Conclusions 
1. The efficiency of oleuropein against microbes was verified, with the optimum 
concentration being 0.6% w/v, which can be used in pharmaceuticals as preservatives. 
2. The effectiveness of OLE against microbes was verified where the optimum 
concentration was 0.4% w/v, which can be used in pharmaceuticals as preservatives. 
3. The effectiveness of thyme oil against microbes was verified where the concentration 
was 0.1% v/v, effective against bacterial only. 
4. The effectiveness of a mixture between oleuropein and thyme oil against microbes was 
verified where the concentration was (0.4% w/v and 0.1% v/v,) which can be used in 
pharmaceuticals as preservatives. 
5. The effectiveness of thyme oil against microbes was verified where the concentration 
was 0.1% v/v, which can be used antibacterial only. 
6. OLE is better than oleuropein where the concentration used is less. 
7. The efficacy of oleuropein and thyme oil was verified within the pharmaceutical 
preparations as it carried a synergistic activity between them and the result against 
microbes was acceptable. 
8. Addition of natural substances oleuropein and thyme oil did not affect the pH of the 
pharmaceutical formulations. 
9. The effectiveness of pharmaceutical preparations against microbes was verified by the 
presence of natural substances oleuropein and thyme oil and the result was acceptable. 
10. Addition of natural substances did not affect the content of active ingredient in 
pharmaceuticals for three months. 
11. Natural substances in the pharmaceutical formulations were stable and effective. 
5.2 Future work: 
1. Evaluation of Oleuropein and thyme oil   in pharmaceutical syrup for one year 
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2. Evaluation of Oleuropein and thyme oil in pharmaceutical semi-solids as preservative 
and antioxidant. 
3. Evaluation of Oleuropein and OLE in the coating of tablets as preservatives. 
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استخدام مستخمصات الأوراق الطبيعية كبديل لممواد الحافظة الاصطناعية ومضادات 
 الأكسدة في الشراب الصيدلاني
 إعداد: محمود نعيم محمود صبيح
 إشراف: الدكتور فؤاد الريماوي
 الممخص 
ذا ونعصديرررر وةصديرررر وضررررةوودكي يصئيرررر  (اوالأكسررررة  ضررررصةا وفووتعتبررررمواد ررررفاةوادمصنظرررر واد  رررر ع 
و ر ودهرصود رصو؛اد رفاةوادكي يصئير ودلمرةو ر واسرتمةا وفدكر ون رصرومةبر و تدايرة والأكسرة  اد يكمفبرص وفضرةو
ن رصرووأ ربم فبصدترصد وو ما وطفيلر ترة رةواسرتمةا هصودفوالأطفرص ثصموجص بي وكبيم وفس ي ومص  وةلىوآ
و ضررةواد يكمفبررص واد سررببونعصديرر فاةوطبيعيرر ودهررصومصجرر و لمرر ودتطررفيمو  تجررص و رريةد ي وبصسررتمةا و رر
وو.الأكسة ادقةم وضةوة لي ووفأيضص وو فدهصوقةم ودلع  وضةواد يكمفبص ودلأ ماض 
ادديترررررررف ووأفماقديررررررر واددةترررررررموف سرررررررتمل و:وقيررررررري و رررررررفاةوطبيعيررررررر تادهرررررررةهو ررررررر ونرررررررذ وادةماسررررررر ونرررررررفو
ف رررفةي و ررر وو  فجبررر وةرررما امرررة وفوفوو سرررصدب وةرررما واث تررري و؛ميرررصتيبكوأ رررفاع وضرررةوثررر  وnieporueloف(
% و0.2(و متلفرر وادديتررف وبررث  وتماكيرردوأفماقميرر وترر وامتبررصمو سررتمل وو  ةفرر ادفطميررص و(م يررم وفو
فدير واددةترمو%  و0.2% و0.2% و0.2(و متلفر و وبث  وتماكيدnieporueloف(و%  0.2% و0.2
يررر وكرررص وم% و0.2%وف0.2(و وبتمكيررردnieporueloفملررريطو ررر وديررر واددةترررموف(و%  0.2(وبتمكيرررد
فملريطوبري ووادديترف وأفماق  و ستمل وو% 0.2( وفnieporuelo  و(و% 0.2(ونفوالأ ث ادتمكيدو
ميرررررررر وأظهررررررررموادملرررررررريطو  ررررررررصطوترررررررر دم وبرررررررري وو% 0.2%وفو0.2(و وفديرررررررر واددةتررررررررمnieporuelo(
و.ستمة وك فاةومصنظ توأ ادت وي ك وو وفدي واددةتمnieporuelo(
وأفماق وفديرر واددةتررموف سررتمل وnieporueloةوادطبيعيرر و(ترر واسررتمةا واد ررفاوةلررىونررذ واد تررصئ وب ررص  و
% و0.2(و وبتمكيردnieporueloمير وتر واسرتمةا و رصة و(و  ستمضما و ريةد ي و ادديتف وةام وث ث
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ت ووفأيضص و .وpuryS larO etahpsohP muidoS enosahtemaxeD واد ستمضمواد يةد  و(ن
.وفتررر واسرررتمةا و رررصة ونررر و فرررتواد ستمضرررمو% 0.2(وادديترررف وبتمكيررردوأفماقاسرررتمةا و رررصة و سرررتمل و
ةامررررر واد ستمضرررررمواد ررررريةد  وو% 0.2(وفديررررر واددةترررررموبتمكيررررردو% 0.2(و وبتمكيررررردnieporuelo(
فدير وو% 0.2(و وبتمكيردnieporueloتر واسرتمةا و رصة و( وفوyarpS lasaN edirolhC muidoS(
و. sporD larO 3D nimatiV(وةام واد ستمضمواد يةد  و% 0.2(واددةتموبتمكيد
اد ستمضررررما واد رررريةد ي ود ررررة وثرررر  و ررررهفموميرررر وترررر وامتبررررصمونعصديرررر ووثبصتيرررر وفاسررررتقماموترررر وامتبررررصم
م رررصئ وادفيديصئيررر وتررر وامتبرررصمووفأيضرررص ووالأكسرررة  اد يكمفبرررص وفضرررةوواد ستمضرررما واد ررريةد ي وضرررة
و ادفعصدررر دل ستمضرررما واد ررريةد ي و ثرر وادرررمق وادهيرررةمفجي  وفادلررف وفادتمسررريةوفاد ظهرررموف سررب واد رررصة و
و. nieporuelo(ادطبيعي وو صة ادوفأيضص و
 رر وادمفررظوتمرر وادظررمفهوواد ستمضررما واد رريةد ي ود ررة وثرر  و ررهفموثبصتيرر واد تررصئ وأ ررصم ميرر و
م رصئ وادفيديصئير ودل ستمضرما واد ريةد ي وادوفأيضرص وو فعصدير وضرةواد يكمفبرص اد  ومي واد تسصمة و
ومق وادهيةمفجي  .وفاد صة وادفعصد وفادو nieporuelo( صة وو سب وإدىوبصلإضصن 
و
